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 Abstract 
Inflammatory diseases such as hypertension are associated with high levels of 
oxidative stress. Characteristic of oxidative stress is the inflammatory acute phase 
protein response. Oxidative stress and its accompanied inflammation can be reduced via 
phase 2 enzyme induction. Broccoli sprouts, a rich source of phase 2 enzyme inducers 
such as isothiocyanates, can be incorporated into the diet to increase phase 2 enzymes. 
The hypothesis of this study is that, the dietary intake of dried broccoli sprouts, by 
inducing liver phase 2 enzymes, will decrease oxidative stress and the acute phase 
response in the blood of spontaneously hypertensive stroke-prone rats.  
Spontaneously hypertensive stroke-prone rats (SHRsp) and Sprague Dawley 
(SD) rats were placed either on a control diet of modified AIN-93G or an experimental 
diet of modified AIN-93G supplemented with dried broccoli sprouts. The following 
parameters were examined: 1. Isothiocyanate absorption (an increased level of 
dithiocarbamates is reflective of ITC absorption), 2. Oxidative stress (a reduction in 
oxidative stress is evidenced by an increase in plasma protein thiols and blood 
glutathione (GSH)), 3. Acute phase proteins (a decreased APR is reflected by an 
increase in plasma albumin and a decrease in ceruloplasmin), 4. Activity of phase 2 
enzymes (increased phase 2 enzyme induction results in higher activities of liver 
quinone reductase (QR), glutathione-S-transferase (GST) and glutathione reductase 
(GR)).  
My experimental results demonstrated that broccoli sprout feeding results in 
higher protein thiol levels in female SHRsp and higher blood GSH levels in males but no 
acute phase protein changes were observed in either male or female SHRsp. Broccoli 
sprout feeding caused higher QR and lower GST activities in female SHRsp but did not 
 ii
 affect the activities of phase 2 enzymes in male SHRsp. The activities of GST and QR 
were higher in SD rats than in SHRsp. Levels of dithiocarbamates were higher in the 
broccoli fed group than in the control fed group. 
The results from this study do not present a clear pattern to support the 
hypothesis that dietary intake of broccoli sprouts by inducing phase 2 enzymes will 
decrease parameters of oxidative stress and the acute phase response. In conclusion, 
there is an interactive role played by animal gender and the induction of phase 2 
enzymes by dried broccoli sprouts. 
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Chapter 1 Introduction 
1.1. Rationale 
During oxidative stress, reactive oxygen species (ROS) can activate transcription 
factors such as Nuclear Factor Kappa B (NF-κB) (Pinkus et al., 1996). Prolonged 
activation of NF-κB results in chronic inflammation (Makarov, 2000). Characteristic of 
NF-κB activation are a wide array of pro-inflammatory genes including Interleukin-6 (IL-
6). IL-6 is a cytokine that modulates the acute phase response (APR). During the APR, 
acute phase proteins (APP) are produced (Shreiber, 1987). Some APP decrease during 
inflammation (negative APP) whilst others increase (positive APP). In the rat, albumin is 
an example of a negative APP and ceruloplasmin (CP) is an example of a positive APP. 
The APR is considered to be a marker of inflammation. Since the APR is a marker of 
inflammation, an APR should be present under conditions of oxidative stress.  
ROS can act as signalling molecules under normal physiological conditions. 
However during oxidative stress, ROS can cause damage to deoxyribonucleic acid 
(DNA), lipids and proteins (Bourdon and Blache, 2001). It is desirable for cells to 
adequately scavenge ROS. Oxidant scavenging can occur via both enzymatic and non-
enzymatic methods (Halliwell and Gutteridge, 1990). Of particular importance to this 
project are phase 2 enzymes that are involved in cellular detoxification processes and 
oxidant scavenging. Phase 2 enzymes are important in regulating the redox balance of the 
cell, and decreasing oxidative stress (Juurlink, 2001).  
Phase 2 enzyme inducers can cause an upregulation in the synthesis of phase 2 
enzymes. Phase 2 enzyme inducers, including tert-butyl-hydroquinone (tBHQ) and 
sulforaphane (Sul), are electrophilic compounds that are able to modify sulfhydryl 
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residues. Glucoraphanin found in broccoli sprouts, is converted into the isothiocyanate 
(ITC) Sul via the enzyme myrosinase (Fahey et al., 1997). Administration of phase 2 
enzyme inducers should result in phase 2 enzyme induction and consequently a decrease 
in oxidative stress (see Figure 1). 
 
 
 
 
 
 
 
 
 
 
    
B.  Oxidative stress
NF-κB activation 
Pro-inflammatory genes 
for e.g. IL-6 
APR (occurs 
in the liver) 
Phase 2 enzyme 
inducer e.g. 
sulforaphane 
APPs e.g. 
albumin and 
ceruloplasmin 
Figure 1. A proposed model by which feeding of a dietary phase 2 enzyme inducer 
decreases oxidative stress and the acute phase response. Oxidative stress results in 
NF-κB activation. This results in the transcription of pro-inflammatory products such as 
IL-6. IL-6 mediates the APR in the liver and gives rise to APP such as albumin and 
ceruloplasmin. Phase 2 enzyme inducers decrease levels of oxidative stress. 
 
1.2. Hypothesis 
Dietary intake of broccoli sprouts, by inducing phase 2 enzymes in the liver, will 
decrease oxidative stress and the acute phase protein response (APR) in the blood of 
spontaneously hypertensive stroke-prone rats (SHRsp).   
 
 
 2
  
1.3. Objectives 
Blood analysis 
1. To determine if ITCs from broccoli sprouts are detectable in the plasma of 
SHRsp.  
2. To determine if the daily feeding of 200 mg of dried broccoli sprouts to male and 
female SHRsp reduces oxidative stress as reflected by an increase in levels of 
plasma protein thiols and blood glutathione (GSH). 
3. To determine if the daily feeding of 200 mg of dried broccoli sprouts to male and 
female SHRsp reduces parameters of the APR as reflected by a decrease in levels 
of plasma ceruloplasmin and an increase in levels of albumin. 
Liver Analysis 
4. To determine if 200 mg of broccoli sprouts induces phase 2 enzymes in the livers 
of SHRsp as shown by an increase in glutathione reductase (GR), glutathione-S-
transferase (GST), and quinone reductase (QR) activity. 
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Chapter 2 Literature Review 
2.1 Oxidative stress 
2.1.1 Background  
Oxygen, which is central to our existence, plays a key role in oxidation and 
reduction reactions. Oxidizing agents take electrons from other compounds or add 
oxygen to them (Halliwell, 1994). Likewise, reducing agents donate electrons or remove 
oxygen (Figure 2.1).  
 
 
 
 
 
 
 
Addition 
X• + Y → [X⎯Y]•  (a) 
Donation 
X• + Y → X+ + Y•-  (b) 
Removal 
X• + Y → X- + Y•+   (c) 
Combination 
X• + X• → X2 
X• + Y• → XY    (d) 
Figure 2.1 How radicals beget radicals: a fundamental principle of free radical 
chemistry. (Reprinted from J Lab Clin Med, 119 (6), Halliwell, B., Gutteridge, J. M., and 
Cross, C. E, Free radicals, antioxidants, and human disease: where are we now?, pages 
598-620, 1992, with permission from Elsevier). X•  is a free radical and Y is non free 
radical. Equations (a-c) demonstrate the effects of combining a free radical with a non 
free radical or in equation (d) with another free radical (Y•)   
 
Oxidizing or reducing reactions can generate free radicals. A free radical is “any 
species capable of independent existence (hence the term ‘free’) that contains one or 
more unpaired electrons” (as reviewed in Gutteridge, 1994). By this definition, oxygen 
which has 2 unpaired electrons is a free radical (as reviewed in Halliwell, 1994), whereas 
hydrogen peroxide (H2O2), which has no unpaired electrons is not a free radical. H2O2 is 
classified as a ROS. ROS are compounds that are derived from oxygen such as 
superoxide, the hydroxyl radical, hypochlorous acid and ozone. Superoxide and H2O2 are 
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not very reactive but still fall under the term ROS (as reviewed in Halliwell, 1994), as 
they can react with other free radicals to create species that are highly reactive. Likewise, 
reactive nitrogen species (RNS) describe molecules that are nitrogen derivatives. ROS 
and RNS are the most commonly encountered species during oxidative stress.   
Under non-pathological conditions, the endogenous antioxidant system scavenges 
ROS and RNS ensuring that cellular damage is minimised. However during pathological 
conditions, ROS and RNS overwhelm the endogenous antioxidant system, giving rise to a 
condition known as oxidative stress. During conditions of oxidative stress, the generation 
of free radicals can have several consequences. They can regulate signalling pathways 
that activate transcription factors such as NF-κB (Kaul et al., 1998; Schmidt et al., 1996). 
Free radicals can react with and cause damage to DNA, lipids and proteins (as reviewed 
in Bourdon and Blache, 2001). They can play a role in the pathogenesis of diseases such 
as hypertension that have an underlying inflammatory component. 
2.1.1.1  The generation of ROS and RNS 
ROS and RNS are formed during normal physiological processes that occur when the 
cell is not under stress. For example, this occurs within the electron transport chain (see 
Figure 2.2). Of respired oxygen, 98% is utilized by mitochondria to generate adenosine 
triphosphate (ATP) (Duchen, 2004). The breakdown and oxidation of foods generates 
electrons that are passed onto electron carriers such as flavin adenine dinucleotide (FAD) 
or nicotinamide adenine dinucleotide (NAD+) and then into the electron transport chain to 
generate ATP. Within the electron transport chain, oxygen receives a hydrogen ion and 
electrons and is reduced to water. During this process, premature leakage of an electron 
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to oxygen leads to the formation of superoxide (O2•−) (Kamata and Hirata, 1999) (See 
reaction 1 in Table 2.1).  
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can give rise to other RNS (Droge, 2002). ROS and RNS that are generated during 
normal physiological conditions are scavenged by intracellular and extracellular 
antioxidant systems. During pathological states antioxidant systems may be overwhelmed 
by the excess production of oxidants. For example during hypertension excess production 
of superoxide acts as a sink for the vasodilator NO•. This decreases the bioavailability of 
NO• reducing vascular relaxation. 
Table 2.1 Oxidative stress related reactions. 
 
1) O2 + e- → O2•- (superoxide radical) 
2) Superoxide dismutase: 2O2•- + 2H+ → H2O2 + O2 
3) Fe2+ + H2O2 → Fe3+  + OH• + OH- (Fenton reaction) 
4) O2•- + NO• →ONOO- 
5) LOO• + TOH → LOOH + TO• 
6) TO• + AscH2 → TOH + AscH• 
7) 2AscH• → AscH2 + Asc 
8) 2GSH + Asc → GSSG + AscH2 
9) γ-glutamylcysteine ligase: L-glutamate + L-cysteine + MgATP→ L-γ-glutamyl-L-cysteine + MgADP +Pi 
10) Glutathione synthase: L-γ-glutamyl-L-cysteine + Glycine + MgATP → Glutathione + MgADP + Pi  
11) Glutathione-S-transferase: GSH + R-X → GSR + HX 
12) Glutathione Peroxidase: LOOH + 2GSH  → HOH + GSSG 
13) Glutathione Reductase: GSSG + 2NADPH → 2GSH + 2NADP+ 
14) Catalase: 2H2O2 → 2H2O + O2 
15) LH + OH• → L• + HOH 
16) L• + O2 → LOO• 
17) LH + LOO• → L• + LOOH 
18) LOOH + Fe2+ → Fe3+ + LO• + OH- 
19) LOOH + Fe3+ → Fe2+ + LOO• + H+ 
20) Myeloperoxidase: Cl- + HOOH→ OCl- + H2O 
21) Fe2+ + O2→ Fe3+ +O2•-   
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2.1.2 Antioxidant defence systems 
 Antioxidant systems can be enzymatic or non-enzymatic and differ in importance 
depending on whether they are intracellular or extracellular. This is summarized in Table 
2.2. 
Table 2.2. Some important antioxidants of biological systems. (Reprinted from Best 
Practice and Research Clinical Haematology, 2 (2), Gutteridge, B. and Halliwell, J. M.,   
Iron toxicity and oxygen radicals, pages 195-256, 1989, with permission from Elsevier) 
  
Antioxidant  Mode of action 
Intracellular  
Superoxide dismutases (Cu, Zn and Mn 
enzymes) 
Removal of superoxide radical (O2-) 
Catalase (heme protein) Removal of hydrogen peroxide (H2O2) 
Glutathione peroxidase (selenium enzyme) Removal of hydrogen peroxide and 
probably organic hydroperoxides (LOOH) 
after cleavage  from membranes 
Membrane  
Vitamin E Lipid-soluble, lipid radical , chain-breaking 
antioxidant (LO•  and LO2• ) 
β-carotene Singlet oxygen and OH•  radical scavenger 
Extracellular fluids  
Transferrin Binds Fe3+ and stops its participating in 
radical reactions 
Lactoferrin Binds Fe3+  at low pH values and stops  its 
participation in radical reactions 
Ceruloplasmin Catalyses the oxidation of ferrous ions to 
the ferric state (ferroxidase activity). Can 
react stoichiometrically with O2- 
Haptoglobins and haemopexin Bind free hemoglobin/ heme and prevent 
lipid peroxide decomposition 
Albumin Binds copper tightly and iron weakly. 
Probably a ‘site specific’ sacrificial 
antioxidant 
Extracellular superoxide dismutase (copper 
protein) 
High-molecular-mass glycoprotein which 
removes O2-. May be located at endothelial 
cell surface. (Only trace amounts present) 
Urate (uric acid) Inhibitor of radical reactions can also bind 
iron and copper ions. 
Glucose 
 
High rate constant for reaction with OH• 
radicals. Present at 3-5mM or even higher 
after a carbohydrate rich meal 
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2.1.2.1 Non-enzymatic defence system 
Flavonoids, beta carotene and lycopenes constitute part of the non-enzymatic 
defence system. They play a role in iron chelation, inhibition of lipid peroxidation, 
decreasing cell adhesion molecules and scavenging free radicals such as peroxynitrite (as 
reviewed in Paterson, 1999). However, the most common non-enzymatic defence 
systems include vitamin C (which was omitted by Gutteridge et al in Table 2.2), vitamin 
E (tocopherol) and GSH. Vitamin E plays a major role in breaking the chain of lipid 
peroxidation that occurs in membranes, by binding peroxyl radicals (as reviewed in 
Halliwell and Cross, 1994; Juurlink, 1999) (See reaction 5 in Table 2.1). During this 
reaction, vitamin E becomes a free radical that is reduced by ascorbate (See reaction 6 in 
Table 2.1). This causes ascorbate to dismutate to oxidized ascorbate (See reaction 7 in 
Table 2.1) which is reduced by either nicotinamide adenine dinucleotide phosphate 
(NADPH) or GSH dependant systems (as reviewed in Halliwell, 1994) (See reaction 8 in 
Table 2.1).  
GSH is the most abundant non-protein thiol that exists in millimolar 
concentrations in most cells (Dickinson and Forman, 2002). GSH plays an important role 
in cellular redox buffering. For example, an increase in the ratio of reduced to oxidized 
GSH, decreases the amount of NF-κB activation and consequently the amount of 
oxidative stress (as reviewed in Christman et al., 2000; Juurlink, 1999). Given that 
apoptosis is regulated by the redox state of the cell, GSH also plays a role in regulating 
cell viability (as reviewed in Filomeni et al., 2002).  
 9
  
GSH concentrations are regulated by phase 2 enzymes such as γ-glutamylcysteine 
ligase, GR and GST (as reviewed in Dickinson and Forman, 2002; Juurlink, 1999; Kirlin 
et al., 1999). GSH is made up of the amino acids glutamate, cysteine and glycine. The 
enzyme γ-glutamylcysteine ligase is the rate-limiting enzyme in the production of GSH. 
γ-glutamylcysteine ligase catalyses the formation of glutamate and cysteine giving rise to 
L-γ glutamyl-L cysteine (See reaction 9 in Table 2.1). Since cysteine is the limiting 
amino acid for GSH synthesis, pro-cysteine delivery systems such as L-2-
oxothiozolidine-4-carboxylate or S-adenosyl methionine are used to increase intracellular 
GSH levels. Glutathione synthase catalyses the reaction of L-γ glutamyl-L cysteine with 
glycine, giving rise to GSH (See reaction 10 in Table 2.1). Once formed, enzymes such 
as GST or glutathione peroxidase (GPx) act on GSH. As an electron donor, GSH cycles 
between a reduced and oxidized state. The flavoprotein GR contains a NADPH and FAD 
site. GR catalyses the flow of electrons from NADPH to FAD and then to GSH (See 
reaction 13 in Table 2.1).  
 It has been suggested that plasma proteins, for example CP, hemoglobin and 
transferrin, constitute a major part of the non-enzymatic extracellular antioxidant defence 
system. They bind transition metal ions to prevent them from reacting to generate toxic 
species like the hydroxyl radical (as reviewed in Halliwell and Gutteridge, 1990). Some 
of these proteins in addition to being antioxidants are also APP. For example, the copper-
binding protein CP, and the iron binding proteins hemoglobin and transferrin are 
examples of positive APP with antioxidant properties. CP has ferroxidase activity i.e. it is 
able to convert the ferrous cation (Fe2+) into the ferric cation (Fe3+) thus preventing the 
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Fenton reaction. CP is an APP that makes up part of both the enzymatic and non-
enzymatic parts of the antioxidant defence system.  
2.1.2.2 Enzymatic antioxidant defence system 
The cell’s main antioxidant defence systems are the enzyme systems of SOD, 
catalase, GPx, and GST (as reviewed in Halliwell and Gutteridge, 1990). They play a role 
in eliminating superoxides, peroxides, and xenobiotic compounds. SOD converts 
superoxide into H2O2. Catalase and GPx play a role in converting H2O2 to water and 
oxygen (See reaction 12 and 14 in Table 2.1). The advantage of GPx over the enzyme 
catalase is that the affinity of GPx for H2O2 is higher and GPx is not localized to 
peroxisomes as is catalase. GST catalyses the formation of glutathiol adducts (See 
reaction 11in Table 2.1) eliminating xenobiotic compounds. 
In blood plasma, the enzyme systems of SOD, catalase, and GPx do not make up the 
main antioxidant systems, as their concentrations are too low (as reviewed in Halliwell 
and Gutteridge, 1990). Also, with respect to GPx, the amount of reduced GSH in rat 
plasma is in the range of about 20 µM, and GPx requires millimolar concentrations to 
function (as reviewed in Halliwell and Gutteridge, 1990). It has been found, however, 
that thioredoxin (Trx) and glutaredoxin may act as electron donors to human plasma GPx 
(Bjornstedt et al., 1994). This might explain the presence of GPx despite the low 
concentration of GSH in plasma. The next section deals with the consequences of 
oxidative stress that exist when antioxidant systems are overwhelmed by excess oxidant 
generation. 
2.1.3 Consequences of oxidative stress 
2.1.3.1 NF-κB 
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2.1.3.1.1 Overview 
As part of a normal physiological defence mechanism, immune cells such as 
neutrophils, macrophages, and lymphocytes respond to infiltrating micro-organisms via 
NF-κB activation (as reviewed in Baeuerle, 1998; Makarov, 2000). NF-κB activation can 
also be mediated by ROS such as H2O2 (as reviewed in Li and Karin, 1999). In the 
absence of invading micro-organisms and in the presence of oxidative stress, oxidants 
can inappropriately activate NF-κB (Flohe et al., 1997; Janssen-Heininger et al., 2000; 
May and Ghosh, 1998; Pinkus et al., 1996). Antioxidants help to maintain the redox state 
of the cell, and are thought to counteract NF-κB activation. Interleukin-1 induced 
activation of NF-κB was enhanced when inhibitors of GPx, GR and catalase were 
administered (Renard et al., 1997). Maintaining the antioxidant defence system of a cell 
decreases oxidative stress and NF-κB activation, thereby avoiding NF-κB mediated pro-
inflammatory pathways that result in cellular damage. 
2.1.3.1.2 Mechanism of NF-κB activation 
NF-κB in its inactive form resides in the cytoplasm where its nuclear localization 
site is masked by inhibitory proteins (as reviewed in Baeuerle, 1998; May and Ghosh, 
1998). Prototypic NF-κB consists of a p50 and a p65 subunit (Brand et al., 1996). Upon 
activation, NF-κB translocates to the nucleus where it results in the transcription of over 
60 pro-inflammatory genes, involved in cell adhesion, immune stimulation, apoptosis, 
chemoattraction, differentiation, extracellular matrix degradation, and redox metabolism 
(Baeuerle, 1998). The upregulation of these genes gives rise to the production of more 
oxidants (as reviewed in Juurlink, 2001). Prolonged activation of NF-κB and the 
upregulation of these pro-inflammatory genes perpetuates a cycle of inflammation, which 
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in the absence of invading organisms is not desirable (Lee and Burckart, 1998). 
Characteristic of chronic or recurring inflammation is the APR, which is regulated by IL-
6.   
2.1.3.2 Acute phase response 
2.1.3.2.1 Overview 
In response to inflammation, an APR occurs in the liver. The APR is considered 
to be a marker of acute inflammation, but components of it persist during chronic 
inflammation (as reviewed in Ceciliani et al., 2002). The APR is characterized by a 
change in production of a set of proteins known as APP (as reviewed in Shreiber, 1987). 
The definition of an APP is one “whose plasma concentration changes by 25% or more 
following inflammatory stimulus” (Mackiewicz, 1993). Positive APP increase in 
response to inflammation whereas negative APP decrease in response to inflammation 
(Mackiewicz, 1993). Examples of positive APP are CP, haptoglobin, fibrinogen and 
transferrin. Albumin is an example of a negative APP (see Table 2.3). It has been 
suggested that the APP pattern of expression occurs to decrease the production of certain 
proteins allowing for the production of others, as there is no need for a drastic increase in 
the overall amount of ATP or transfer ribonucleic acid (RNA) needed (Shreiber, 1987).  
2.1.3.2.2 Function 
Some of the metabolic changes that occur during the APP are listed in Table 2.4. 
The function of the APR in response to inflammation is not well understood. The APR 
appears to be a counterattack of the body against infection and an attempt to reach 
homeostasis (as reviewed in Ceciliani et al., 2002). A role for APP as part of an 
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antioxidant defence system is also proposed and as Ceciliani (2002) suggests, this may be 
to prevent some of the tissue damage that occurs during inflammation. 
 
Table 2.3. Examples of acute phase proteins 
 
Positive rat acute phase proteins Negative rat acute phase proteins 
α1- Proteinase inhibitor 
α1-acid glycoprotein 
α2-macroglobin,  
Ceruloplasmin 
 C-reactive protein 
Cysteine proteinase inhibitor 
Fibrinogen 
Haemopexin 
Haptoglobin 
Prekallikrein 
Transferrin 
α1-Inhibitor 3 
Albumin 
Prealbumin 
  
 
Table 2.4. Metabolic effects of acute phase proteins. (Reprinted from Protein Pept Lett 
9, Ceciliani, F., Giordano, A., and Spagnolo, V., The systemic reaction during 
inflammation: the acute phase proteins, pages 211-223, 2002, with permission from 
Bentham Science Publishers Ltd) 
 
Neuroendocrine changes Fever, Poor appetite and somnolence, 
Increased secretion of ACTH, Cortisol and 
Catecholamines. 
Metabolic changes Increased protein catabolism 
Hepatic production of APP 
Increased hepatic lipogenesis 
Increased adipose tissue lipolysis 
Decrease in bone mass 
Increased gluconeogenesis 
 
Hematopoietic changes Anemia (in chronic disease) 
Leukocytosis 
Thrombocytosis 
Changes in non-protein plasma 
constituents 
Hypozincemia, hypoferremia, and 
hypercupremia 
Increased plasma retinol and glutathione 
concentrations 
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2.1.3.2.3 Regulation 
Glucocorticoids and growth factors regulate the activity of cytokines that in turn 
modulate the activity of the APR (as reviewed in Ceciliani et al., 2002). During the APR, 
the cytokine tumour necrosis factor-α (TNF-α) is released followed by interleukin-1β 
(IL-1β), and then IL-6 (van Deventer et al., 1990). The interplay between this network of 
cytokines is complex and not clear. It appears that IL-6 is induced by TNF-α and IL-1 but 
IL-6 also downregulates TNF-α (as reviewed in Ceciliani et al., 2002). The binding of 
IL-6 to its receptor causes the transcription factor nuclear factor IL-6 to translocate to the 
nucleus where it induces the transcription of APP and amplifies the APR. TNF-α 
activates NF-κB and this perpetuates an undesirable chain of inflammation.  
2.1.3.3 Cellular damage 
2.1.3.3.1 Lipid peroxidation 
During conditions of oxidative stress, lipid peroxidation can disrupt cell 
membranes thereby altering membrane fluidity, decreasing cellular membrane potential, 
increasing permeability and ultimately leading to cell death (as reviewed in Halliwell and 
Chirico, 1993; Spatz, 1992). Lipid peroxidation can be mediated by free radicals (as 
reviewed in Halliwell and Gutteridge, 1990; Juurlink, 1999). A carbon centred lipid 
radical forms when a hydroxyl radical removes an electron from a polyunsaturated fatty 
acid (See reaction 15 in Table 2.1). This carbon centred lipid radical can react with 
oxygen to give rise to a lipid peroxyl radical (See reaction 16 in Table 2.1). When a lipid 
peroxyl radical reacts with a polyunsaturated fatty acid a lipid hydroperoxide is formed 
(See reaction 17 in Table 2.1). This lipid hydroperoxide can react with transition metals, 
generating more lipid peroxyl radicals (see reactions 18 and 19 in Table 2.1) and keeping 
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the chain of lipid peroxidation going. Lipid hydroperoxides are also formed via reactions 
involving myeloperoxidase. Activated monocytes/macrophages and neutrophils contain 
myeloperoxidase, which generates hypochlorous acid (See reaction 20 in Table 2.1). 
Hypochlorous acid can give rise to lipid hydroperoxides.   
 Transition metal ions such as iron affect the rate of lipid peroxidation (as 
reviewed in Aust et al., 1990). Fe2+ is autooxidized to Fe3+ by oxygen (See reaction 21 in 
Table 2.1), as well as peroxides including lipid peroxides and the hydroxyl radical. Lipid 
hydroperoxides can react with Fe3+ giving rise to lipid peroxyl radicals. When iron is 
chelated by iron binding proteins the rate of lipid peroxidation decreases (as reviewed in 
Gutteridge and Halliwell, 1989). Therefore, iron-binding proteins play an antioxidant 
role. During conditions of oxidative stress, damage to iron binding proteins increases the 
rate of lipid peroxidation. 
2.1.3.3.2 Protein damage 
Oxidative stress disables the normal functioning of many proteins, some of which 
include key antioxidant proteins, phosphatases, mitochondrial proteins and transcription 
factors. Given that free metal ions such as iron exacerbate conditions of oxidative stress, 
iron binding proteins such as ferritin and hemoglobin are key antioxidant proteins. Free 
radicals cause iron-binding proteins to release iron (as reviewed in Gutteridge and 
Halliwell, 1989). For example, in stimulated microglia superoxide caused ferritin to 
release iron (Yoshida et al., 1995). The antioxidant enzyme GR is also susceptible to 
oxidative stress. It is inactivated by advanced glycation products (Morgan et al., 2002), 
nitrosylation (Fujii et al., 2000), hydroxynonenal, an oxidative lipid breakdown product, 
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and sulfhydryl oxidation (Becker et al., 1998). Inactivation of GR disrupts GSH 
homeostasis.  
In addition to antioxidant proteins, other proteins such as phosphatases are 
affected by oxidative stress. Phosphatases contain sulfhydryl groups that act like switches 
being activated and inactivated by reduction/oxidation reactions during normal 
physiological reactions. Certain ROS such as hypochlorous acid easily oxidize sulfur 
amino acids (Winterbourn, 2002). Therefore, theoretically excess hypochlorous acid can 
inactivate phosphatases disrupting cellular signalling pathways. 
Several mitochondrial proteins, such as cytochrome oxidase and mitochondrial 
pore proteins are affected by oxidative stress. The enzyme, cytochrome oxidase that 
reduces oxygen in the electron transport chain, can be bound reversibly by NO• (as 
reviewed in Moncada and Erusalimsky, 2002). The ratio between NO• and O2•- is 
suggested to act as an oxygen sensor for oxygen usage (as reviewed in Moncada and 
Erusalimsky, 2002). Moncada et al., (2002) suggest that inhibition of cytochrome oxidase 
by excess NO• results in more available oxygen, ATP depletion and possibly cell death 
(as reviewed in Moncada and Erusalimsky, 2002).  
As electrons are moved through the electron transport chain in the inner 
mitochondrial membrane, protons are moved from the mitochondrial membrane into the 
intermembrane space, generating an electrochemical potential (Lehninger, 1995; as 
reviewed in Moncada and Erusalimsky, 2002). The proton motive force is used to 
generate ATP (as reviewed in Moncada and Erusalimsky, 2002) and is also associated 
with calcium accumulation in the cell (as reviewed in Duchen, 2004). Increases in 
extramitochondrial calcium result in an uptake of calcium into the mitochondria. 
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Intramitochondrial calcium exits via the Na+/Ca2+ exchanger or the permeability 
transition pore. This pore appears to be regulated by sulfhydryls that during times of 
oxidative stress are oxidized and thereby opened. Opening of the pore is associated with 
cytochrome c release, which is pro-apoptotic. Irreversible opening of the pore leads to 
necrotic cell death (as reviewed in Duchen, 2004). Other than the mitochondrial transition 
pore, calcium release into the intracellular space occurs through other mechanisms. 
During oxidative stress, the oxidation of calcium binding proteins increases levels of 
intracellular calcium (as reviewed in Halliwell, 1994). Increased levels of calcium 
activate nucleases, proteases and other calcium dependant enzymes such as calpains and 
phospholipase C (as reviewed in Halliwell, 1994; Juurlink, 1999). The activation of 
calpains gives rise to superoxide whilst that of phospholipase C results in arachidonic 
acid release (as reviewed in Juurlink, 1999). Increased calcium is undesirable and leads to 
mitochondrial damage and consequently cell death (as reviewed in Juurlink, 1999).  
The activity of proteins such as the transcription factor NF-κB is affected by 
oxidative stress. An oxidizing environment in the cytosol promotes NF-κB translocation. 
Prolonged conditions of oxidative stress can cause excess activation of NF-κB, 
perpetuating a cycle of chronic inflammation (Makarov, 2000).  
 
2.1.3.3.3 DNA damage 
Free radicals such as the hydroxyl radical, NO• and lipid breakdown products 
such as hydroxynonenal react with DNA to affect replication, signalling cascades and the 
cell cycle (Moncada and Erusalimsky, 2002). Consequently, DNA mutations can cause 
cancer, thereby increasing inflammation, oxidative stress and/or apoptosis. Mitochondrial 
DNA is particularly susceptible to oxidative attack. It does not contain histones and 
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therefore it is highly accessible to free radicals. Mitochondrial DNA is in close proximity 
to the electron transport chain, which is a major generator of superoxide. This increases 
the probability of superoxide reacting with mitochondrial DNA. Mitochondrial DNA 
mutations, by disrupting the normal activity of genes involved in energy production, may 
interrupt ATP synthesis ultimately leading to cell death.  
2.1.4 SHRsp as a model of inflammation 
2.1.4.1 Background  
 The animal model of inflammation used in this project is the SHRsp. This rat 
model was selectively bred from a strain of spontaneously hypertensive rats (SHR) in 
1974 (Okamoto et al., 1975). The spontaneously hypertensive rats were derived from 
brother-sister breeding of Wistar Kyoto rats (WKY). SHRsp are well characterized as a 
model for studying stroke pathogenesis and hypertension. They are less characterized as a 
model for studying premature ageing, mental impairment and insulin resistance. 
Underlying many of these conditions is oxidative stress. Antioxidant therapy is effective 
at decreasing oxidative stress and consequent inflammation in SHRsp.  
2.1.4.2 Stroke pathogenesis 
Whilst the blood pressure of spontaneously hypertensive rats reaches 200 mm Hg, 
that of the SHRsp reaches up to 230 mm Hg. SHRsp develop hypertension over time that 
is linked to stroke incidence (Okamoto et al., 1975). At blood pressures under 200 mm 
Hg, stroke occurrence is not common (Okamoto et al., 1975). Lowering blood pressure 
decreases stroke incidence in the SHRsp (Okamoto et al., 1975). SHRsp experience both 
cerebral hemorrhage and infarcts and inflammation appears to underlie stroke 
pathogenesis.  
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APP are indicators of inflammation, and APP that correlate with stroke onset are 
detected in the serum of SHRsp (Sironi et al., 2001). Stroke onset was delayed by the 
administration of the statin, cervistatin (Kawashima et al., 2003). Since cervistatin 
decreased parameters of oxidative stress in the brain such as infiltrating inflammatory 
cells and excess superoxide production (Kawashima et al., 2003), a decrease in oxidative 
stress appears to be responsible for delaying stroke onset in SHRsp.  
Diet plays an important role in the timing of stroke onset in SHRsp. The 
administration of a diet with a lower protein content causes strokes to occur quicker in 
SHRsp (Sarwar et al., 1999, Wexler, 1983). Also stroke occurs sooner in SHRsp 
consuming 1% sodium chloride (NaCl) than in SHRsp on tap water. Supplementation 
with NaCl and a diet low in protein accelerate blood pressure increases and decrease 
longevity from 10 months to approximately 3-4 months (Sarwar et al., 1999, Sironi et al., 
2001). Therefore the diet of SHRsp can be manipulated to offset the timing of stroke 
occurrence. However the genetics of these animals still predisposes them to other 
diseases such as hypertension. 
2.1.4.3 Hypertension 
SHRsp are a useful model for studying hypertension. Blood pressure is largely 
affected by arteriolar radius and blood viscosity (Sherwood, 1997). Factors that 
contribute to arteriolar radius include properties of the smooth muscle cells’ and blood 
volume regulation. The myogenic response (spontaneous contractile ability of smooth 
muscle cells) and signalling molecules such as NOw and endothelin regulate smooth 
muscle cell contractility. Compounds such as angiotensin, and the sympathetic and 
parasympathetic nervous system regulate blood volume. During hypertension, blood 
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viscosity or arteriolar radius can be increased resulting in higher blood pressure. Several 
causes of hypertension include renal dysfunction, angiotensin deregulation, NOw shortage, 
improper functioning of baroreceptors, or endocrine problems whereby the adrenal cortex 
may produce too much aldosterone (Sherwood, 1997). Many of the characteristics of 
primary hypertension such as renal dysfunction, problems with angiotensin, and 
endothelial dysfunction, have been observed in SHRsp (Griffin et al., 2001; Hamilton et 
al., 2002; Park et al., 2002) making them a good model of hypertension. 
2.1.4.3.1 Renin-angiotensin aldosterone-system (RAAS) and renal dysfunction 
RAAS plays a role in sodium (Na+) reabsorption (Sherwood, 1997). The kidneys 
produce renin that converts angiotensinogen (produced in the liver) into Angiotensin I 
(Ang I). Ang I is converted into Angiotensin II (Ang II) via angiotensin converting 
enzyme (ACE) (produced in the lungs). Ang II increases vasopressin, which increases 
water retention in the kidney, causes vasoconstriction and acts on the adrenal cortex to 
release aldosterone. The overall effect of RAAS is Na+ retention that results in an 
increased plasma volume.  
 
 
 
 
 
 
 
Figure 2.3. The renin-angiotenisin-aldosterone system 
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Ang II plays a role in cell proliferation/growth, blood pressure regulation, aldosterone 
release, sodium resorption, and serves as a pro-inflammatory mediator. Ang II is 
associated with endothelial dysfunction that is exhibited by an increased expression of 
adhesion molecules and activated monocytes. Ang II increases the pro-inflammatory 
cytokine IL-6, activates NADPH oxidase that generates superoxide, increases endothelin 
production, and activates NF-κB activity (as reviewed in Ruiz-Ortega et al., 2001). 
Monocytes in vascular lesions release ACE therefore increasing levels of Ang II (as 
reviewed in Ruiz-Ortega et al., 2001). Increased levels of Ang II result in higher levels of 
oxidative stress and have been implicated in the pathogenesis of hypertension in SHRsp. 
Treatments targeting the RAAS in SHRsp are effective at reducing hypertension (Romero 
and Reckelhoff, 1999) and also renal dysfunction. SHRsp are a good model of renal 
dysfunction. Proteinuria is indicative of kidney disease and in some cases of the 
overproduction of plasma proteins (as reviewed in Schrier, 2003). SHRsp fed a high 
salt/fat diet, which increases blood pressure, experience albuminuria, a marker of renal 
dysfunction (Ju et al., 2003). SHRsp are salt sensitive and this sensitivity is associated 
with their hypertension susceptibility and renal damage (Griffin et al., 2001).  
Renal dysfunction in SHRsp is dependent on blood pressure, and therefore drugs that 
lower blood pressure are also renoprotective. For example Ang I receptor antagonists, 
ACE inhibitors, and aldosterone antagonists are renoprotective and lower blood pressure 
(Abrahamsen et al., 2002; Griffin et al., 2003; Griffin et al., 2001). Ang II increases 
levels of aldosterone. In SHRsp, the administration of the ACE inhibitor, captopril, 
reduced blood pressure but not when combined with aldosterone infusion (Rocha et al., 
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1999). This study suggests that aldosterone is a key downstream player in RAAS 
regulating blood pressure in SHRsp.  
 
2.1.4.3.2 NOw bioavailability  
Endothelial cells produce vasoconstrictors, such as endothelin-I, ACE, superoxide 
anions and vasorelaxants such as NOw (also known as Endothelial derived relaxation 
factor) (as reviewed in Puddu et al., 2000). An imbalance between vasoconstrictors and 
vasodilators contributes to high blood pressure (as reviewed in Safar and Frohlich, 1995). 
Characteristic of hypertension is endothelial dysfunction whereby an increase in 
superoxide reduces NO• bioavailability (as reviewed in McIntyre et al., 1999; Zalba et 
al., 2001). NOw produces renal vasodilation that leads to diuresis and natriuresis that 
lowers blood pressure (as reviewed in McIntyre et al., 1999). Also, NOw acts on smooth 
muscle cells to activate guanylate cyclase, increasing 3’5’ guanosine monophosphate 
(cGMP) that causes smooth muscle cell relaxation (as reviewed in Puddu et al., 2000). A 
decrease in NOw compromises smooth muscle cell relaxation and therefore contributes to 
hypertension. Causes for endothelial dysfunction may be mediated by the kinase, p38 
mitogen activated kinase (MAPK).   
NOw bioavailability is lower in SHRsp as compared to female WKY, which are a 
normotensive rat strain. In hypertension, NADPH oxidase is the main source of 
superoxide (as reviewed in Zalba et al., 2001). Immunocytochemical staining for 
p22phox (reflective of NADPH oxidase) was higher in SHRsp than WKY as was the 
concentration of superoxide generated (Hamilton et al., 2001). NADPH oxidase 
inhibitors prevent the translocation of the various NADPH subunits. By using apocynin, a 
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NADPH oxidase inhibitor, NOw bioavailability increased as was evidenced by more 
vasorelaxation (Hamilton et al., 2002). These studies demonstrate the important role 
played by NADPH oxidase in increasing NOw bioavailability. Levels of superoxide have 
been shown to be higher in SHRsp than in WKY (Kerr et al., 1999). In 16 week old male 
SHRsp fed a diet containing 4% NaCl, administration of the SOD mimetic tempol 
reduced blood pressure, increased the lumen diameter and decreased the width of the 
media, decreased superoxide production and increased total plasma antioxidant status 
(Park et al., 2002). This study by Park et al. validates the crucial role played by 
superoxide in hypertension. Overall a decrease in superoxide, either by inhibiting 
NADPH oxidase or by increasing SOD, can decrease high blood pressure.    
The improper functioning of baroreceptors is associated with NOw bioavailability. 
Baroreceptors in the carotid sinus and aorta detect changes in blood pressure and act to 
regulate blood volume. In the brain stem, the nucleus tractus solitarii and the caudal 
ventrolateral medulla contain the baroreflex pathway. Transfection of endothelial nitric 
oxide synthase into the brainstem of male SHRsp resulted in an improved baroreceptor 
reflex (Kishi et al., 2003). Endothelial nitric oxide synthase is responsible for producing 
NOw in the endothelium. 
2.1.4.3.3 Smooth muscle cell proliferation 
ROS may act via Ang II activation of NF-κB giving rise to vascular smooth muscle 
cell hypertrophy (as reviewed in Zalba et al., 2001) (Irani, 2000). Vascular smooth 
muscle cell hypertrophy is characteristic of hypertension (as reviewed in Zalba et al., 
2001) (Irani, 2000) and has been characterized in SHRsp and SHR. This increased 
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cellular proliferation has been attributed to a decrease in apoptosis (McCarthy and 
Bennett, 2000).  
2.1.4.3.4 Role of p38 MAPK 
Causes of endothelial dysfunction are proposed to act via p38 MAPK activation. In 
human umbilical vein endothelial cells, TNF-α activated p38 MAPK and this resulted in 
an increase in intracellular molecular adhesion molecule expression. Administration of 
p38 MAPK inhibitors blocked this effect (Ju et al., 2003). In SHRsp fed a high salt/fat 
diet, p38 MAPK inhibitors decreased blood pressure, increased vasorelaxation and 
decreased mortality (Ju et al., 2003). As evidenced by this study, p38 MAPK plays an 
important role in mediating blood pressure and vasorelaxation in the SHRsp. However 
given that oxidative stress can activate various signalling pathways and also that there is 
cross talk throughout the tier of kinase cascades, it is plausible that p38MAPK is acting in 
concert with other components of signalling pathways to give rise to the effects observed 
in Ju’s study. 
2.1.4.4 SHRsp as models of disease 
2.1.4.4.1 Premature aging 
SHRsp are described as a model of premature ageing. Parameters of oxidative 
stress such as superoxide or activated inflammatory cells increase with age. Levels of 
messenger ribonucleic acid (mRNA) levels for p22phox, a subunit of NADPH oxidase, 
were higher in older SHRsp than in the younger SHRsp (Hamilton et al., 2002). Levels of 
mRNA for p22 phox are also higher in SHRsp than in WKY (Hamilton et al., 2001). NOw 
bioavailability was also higher in younger SHRsp than in older SHRsp (Hamilton et al., 
2001) When male 10 month old SHRsp were compared to age matched WKY rats fed 
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standard rat chow, parameters of central nervous system inflammation such as activated 
macrophages, nitrotyrosine positive cells and demyelination were increased in SHRsp 
(Ashraf et al., 2004 submitted). 
2.1.4.4.2 Mental impairment 
SHRsp are described as a model of attention deficit hyperactivity disorder and 
also of vascular dementia. Both male and female SHRsp who were 4 weeks old and fed 
standard rat chow were found to be more hyperactive, impulsive and memory impaired 
than age matched WKY (Ueno et al., 2002). Features of vascular dementia such as 
impaired learning-memory and decreased levels of brain acetylcholine and choline are 
observed in SHRsp (Kimura et al., 2000). However no senile plaques or tangles were 
detected. SHRsp are described as a “useful” model for studying vascular dementia 
(Kimura et al., 2000).    
2.1.4.4.3 Insulin resistance 
A comparison of 3 month old WKY to SHRsp demonstrates that in SHRsp 
glucose uptake was reduced in response to insulin (Collison et al., 2000). SHRsp may 
serve as a useful model for understanding mechanisms underlying diabetes. There is a 
strong link between oxidative stress and insulin resistance (Pessler et al., 2001; Tirosh et 
al., 1999). 
2.1.4.5 SHRsp and oxidative stress 
There are clear links between oxidative stress and the models represented by SHRsp. 
Increased levels of superoxide, advanced glycation products, APP, 8-hydroxy-2’-
deoxyguanosine, activated immune cells, Ang II and decreased NOw bioavailability are 
present in SHRsp (Mizutani et al., 2000) (Morgan et al., 2002) (Romero and Reckelhoff, 
 26
  
1999) (Zalba et al., 2001) (Sironi et al., 2001). To what extent oxidative stress is a cause 
or a consequence of the pathologies seen in SHRsp is not clear. Regardless of this 
conundrum SHRsp are still a good model of oxidative stress and therefore inflammation. 
2.1.4.6 Dietary intervention studies 
Blood pressure, superoxide production and NADPH activity were all reduced in 16 
week old SHRsp fed a diet containing 4% NaCl and supplemented with either vitamin E 
or C (Chen et al., 2001). Dietary administration of the polyphenolic compound, 
Resveratrol, a phase 2 enzyme inducer, was found to decrease levels of oxidative stress in 
SHRsp (Mizutani et al., 2000). Consumption of either black or green tea lowered blood 
pressure in SHRsp (Negishi et al., 2004). In cultured aortic smooth muscle cells form 
SHRsp, the isoflavones, genistein, daidzein and glycitein reduced smooth muscle cell 
proliferation (Pan et al., 2001). Dietary administration of antioxidant promoting agents 
decreases oxidative stress in SHRsp. 
2.2  Dried Broccoli Sprouts 
2.2.1 Profile of sprout metabolites 
The genus brassica is one of approximately 350 genera in the cruciferae (also 
known as the brassicaceae) family of vegetables (as reviewed in Fahey, 2001). The 
cruciferae family, characterized by 4 petals or sepals, consists of subspecies such as 
broccoli, kale, brussel sprouts and cauliflower (as reviewed in Verhoeven et al., 1997). In 
our diets, the consumption of crucifers is encouraged for their anti-carcinogenic 
properties. Profiles of crucifers such as broccoli have been shown to contain vitamins, 
fibre, and phytochemicals such as flavonoids, glucosinolates, ITCs and phenols. 
Identifying the roles played by various compounds in crucifers has pointed to broccoli 
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sprouts having protective effects due to their high glucosinolate content (Zhang et al., 
1992). 
Cruciferous plants synthesize glucosinolates, which are β-thioglucoside N-
hydroxysulfates that are known as N-hydroxyiminosulfate esters or S-gluopyranosyl 
thiohydroximates. They contain a side chain and a β-D-glucopyranose moiety attached to 
sulfur. Glucosinolates vary by having either straight or branched side chains, which may 
contain hydroxyl, or carbonyl, or sulfur groups that confer different properties upon 
them. Some brassica vegetables contain glucosinolates that are goitrogenic in certain 
animals, for example, rapeseed in swine and brussel sprouts in rats (Verhoeven et al., 
1997). The effects of goitrogenicity are species and diet dependant. Plant injury, 
mastication or freeze- thaw cycles cause the conversion of glucosinolates to 
isothiocyanates via the enzyme myrosinase. Myrosinase, which is present in plants and 
the microflora of the digestive tract, breaks the β-thiogluoside bond of glucosinolates 
such as glucoraphanin giving rise to glucose, sulfate and aglucons such as the 
isothiocyanate Sul.  
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Environment, genetics and plant age affect the concentration of plant glucosinolates. 
For example, Jeffrey et al. (2003) suggests that plants that are more stressed due to 
handling and pests have higher levels of indole glucosinolates (e.g. gluconeobrassicin) as 
opposed to aliphatic glucosinolates such as glucoraphanin. Indole 3-carbinols are derived 
from trytophan whereas aliphatic glucosinolates are derived from methionine (as 
reviewed in Jeffery, 2003). Profiling of 2 day old broccoli sprouts revealed that less than 
10% of the total sprout glucosinolates were indole glucosinolates (glucobrassicin and 
neoglucobrassicin) compared to 67% in the mature plant (Fahey et al., 1997). Levels of 
methylsulfinylalkyl glucosinolates (glucoraphanin and glucoerucin) were 20 times higher 
in the sprouts (Fahey et al., 1997). 
Certain glucosinolates give rise to monofunctional inducers whilst others give rise to 
bifunctional inducers. For the most part, monofunctional inducers affect phase 2 enzymes 
whilst bifunctional inducers affect both phase 1 and phase 2 enzymes. Indole 
glucosinolates such as indole 3- carbinol and indole 3- nitrile when treated with 
myrosinase give rise to bifunctional inducers such as 3,3’-diidolylmethane and indole –3-
carbazole (Bjeldanes et al., 1991). In contrast, the glucosinolate glucoraphanin gives rise 
to the monofunctional inducer, Sul. Monofunctional inducers such Sul are 
chemoprotective whereas bifunctional inducers have the potential to be pro-carcinogenic. 
Understanding the role of plant genetics, environment and age with regards to 
glucosinolate content is important for obtaining plants that are high in compounds such as 
Sul. 
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2.2.2 Sulforaphane 
Sul, the major inducer of phase 2 protein (Zhang et al., 1992), is protective against 
inflammation and cancer causing agents. The protective effects of Sul have been 
attributed to its ability to induce phase 2 enzymes, inhibit phase 1 enzymes, and affect 
cell cycle arrest and apoptosis (See figure 2.6). Of particular interest to this study is Sul’s 
role with respect to phase 2 enzyme induction. 
 
 
 
 
Figure 2.6. A proposed mechanism by which Sul provides protection. 
Sul
Phase 1 enzymes 
Cell cycle arrest and 
apoptosis Phase 2 enzymes 
2.2.2.1 Phase 2 enzymes 
2.2.2.1.1 Overview of phase 2 enzymes 
Xenobiotics or foreign compounds elicit various responses including homeostasis, 
proliferation, differentiation, apoptosis or necrosis (as reviewed in Rushmore and Kong, 
2002). The body responds to xenobiotics by inducing phase 1 and/or phase 2 enzymes (as 
reviewed in Rushmore and Kong, 2002). Phase 1 enzymes (see section 2.2.2.2) are 
involved in oxidative reactions whereby xenobiotics can be rendered more electrophilic 
(as reviewed in West et al., 1997). Phase 2 enzymes then act on these toxic metabolites 
making them more readily excretable or less harmful to cells (Kirlin et al., 1999). Phase 2 
enzymes also contribute to maintaining the redox balance of the cell. Members of the 
phase 2 enzyme family include QR, GST, epoxide hydrolase, thioredoxin reductase, 
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gamma glutamyl cysteine ligase, GR, and heme oxygenase-1 (Thimmulappa et al., 2002, 
Hintze et al., 2003). 
Xenobiotics such as Sul that regulate levels of phase 2 enzyme activity are known 
as phase 2 enzyme inducers. Characteristic of most phase 2 enzyme inducers are the 
following: they are chemically reactive, electrophilic, GST substrates and they can alter 
sulfhydryl groups (Dinkova-Kostova et al., 2001). The following sections deals with 
Sul’s induction of phase 2 enzymes and the possible involvement of nuclear factor-
erythroid 2p45-related transcription factor (Nrf2) and NF-κB, mediated mechanisms of 
phase 2 enzyme induction. 
2.2.2.2.2 Sulforaphane and phase 2 enzymes 
Sul is protective against the administration of pro-carcinogenic compounds 
(Fahey et al., 2002; Zhang et al., 1994) and during conditions of oxidative stress (Wu et 
al., 2004; Wu and Juurlink, 2001). This protection may be due to Sul’s ability to induce 
phase 2 enzymes. Several studies have shown that Sul directly induces phase 2 enzymes. 
For example, in a human hepatocyte carcinoma cell line (HepG2), in cells that were 
transfected with thioredoxin reductase luciferase reporter construct, the administration of 
0.5, 1.0, or 2 µM of Sul for 24 hours resulted in a dose dependant increase of thioredoxin 
reductase activity (Hintze et al., 2003). In mouse intestine a dose of 3 µmol /gram Sul for 
2 weeks induced QR activity and GST activity (McMahon et al., 2001). In female mice 
liver, GST and QR activities were increased by giving 15 µM of Sul for 5 days (Zhang et 
al., 1992). In smooth muscle cells from both spontaneously hypertensive and 
normotensive rats, Sul concentrations of 0.05-0.5 µM were shown to induce GR (Wu and 
Juurlink, 2001). In stroke prone spontaneously hypertensive rats, the administration of 
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dried broccoli sprouts induces GR in the aorta, carotid and kidney (Wu et al., 2004). 
These studies provide evidence that Sul induces phase 2 enzymes. A plausible 
mechanism for this phase 2 enzyme induction is via the transcription factor Nrf2. 
2.2.2.2.2.1 Nrf2 overview 
Phase 2 enzymes are induced via the antioxidant response element (ARE), which 
is responsive to various inducers (phenolic antioxidants and aromatic compounds) as well 
as H2O2 (Rushmore et al., 1991). The core sequence of the rat ARE is: 5’ (G/A) TGA 
(G/C) NNNGC (G/A)-3’ (Rushmore et al., 1991). A key player in the regulation of the 
ARE is Nrf2. The Nrf family is comprised of Nrf1, 2, and 3. Nrf1 is thought to play a role 
during biological development, whilst Nrf2 is implicated in regulating the basal (Huang 
et al., 2000) and inducible levels of phase 2-enzymes.  
2.2.2.2.2.2 Nrf2 regulation 
Nrf2 mRNA levels stay the same upon Nrf2 activation and translocation into the 
nucleus, therefore Nrf2 is regulated post transcriptionally (Nguyen et al., 2003). In the 
cytosol Nrf2 is regulated by Kelch-like associated protein (Keap1), a negative repressor 
of Nrf2 translocation. In the nucleus, Nrf2 heterodimerizes with Maf proteins, Fos-B, C-
jun, JunD, and activating transcription factor 2 (as reviewed in Hayes and McMahon, 
2001; Motohashi et al., 1997). These partners may regulate Nrf2’s activity in the nucleus 
and consequently the transcription of phase 2 enzymes. 
Nrf1 and 2 have been shown to heterodimerize with Maf G and Maf K. The latter 
are members of the Maf family of proteins which is made up of large proteins (c-Maf and 
MafB) and small proteins (Maf K, Maf F and Maf G). Recently it has been found that 
Maf K is a repressor of the ARE (Nguyen et al., 2000). Maf K and Nrf2 can bind to the 
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QR ARE with high affinity whereas they bind to the GST ARE with low affinity 
(Nguyen et al., 2000). The ability of this Nrf2/ MafK complex to bind with such high 
affinity seems to be dependant on the presence of a palindromic sequence in the QR ARE 
(Nguyen et al., 2000). Maf K repression reduces QR basal expression but not its 
inducible expression. The addition of inducers still leads to an increase in QR, despite 
there being an over expression of Maf K (Nguyen et al., 2000). Palindromic structures in 
the ARE of various phase 2 enzymes may determine the affinity with which Nrf2/Maf 
complexes bind. The regulation of phase 2 enzymes may depend on the type of Maf 
protein that Nrf binds to and the palindromic structures in the ARE of various genes.  
Nrf2 has 6 domains namely, Neh1-6. Neh1 is a basic leucine zipper domain, Neh 
4 and 5 are acidic domains and Neh6 is a serine rich domain (See figure 2.7) (Itoh et al., 
1999) (Itoh et al., 1999). Neh4 and Neh5 are transactivation domains unlike Neh2, which 
contains a conserved carboxy hydrophilic region. Neh2 is the Keap 1 binding site. Keap1 
is a negative repressor of Nrf2 translocation (Itoh et al., 1999). It regulates Nrf2 by 
keeping it bound in the cytosol until the appropriate signal is propagated. Deletion of 
Neh2 results in more potent transactivation of the ARE (Itoh et al., 1999). It is not known 
where Nrf2’s nuclear translocation signal is located. It is possible that Keap1 masks this 
signal, thus maintaining Nrf2 in the cytosol. The location of Nrf2’s nuclear translocation 
signal would help in understanding how Nrf2 translocates into the nucleus. 
Neh 6 Neh 3Neh 2
Neh 5Neh 4
 
Neh 1 
 
 Binding site for Keap1Figure 2.7. A schematic of Nrf2. 
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Keap 1 has 5 domains, which include a double glycine repeat motif, the BTB 
domain, the intervening region (IVR), which has 8 cysteines, an N-terminal repeat and a 
C-terminal region, (Dinkova-Kostova et al., 2002). The DGR motif is used to contact the 
cytoskeleton while the BTB interaction domain of Keap 1 is thought to play a role in the 
dimerization of Keap 1 and Nrf2 (Zipper and Mulcahy, 2002). Deletion of this domain in 
HepG2 cells hinders the ability of Keap 1 to sequester Nrf2 in the cytoplasm (Zipper and 
Mulcahy, 2002). Therefore the Neh2 domain of Nrf2 binds to the BTB domain of Keap 1. 
Sulfhydryl oxidation may release Nrf2 from Keap 1, in the cytosol. Murine Keap 1 has 
25 cysteines and Nrf2 has 7 cysteines (Dinkova-Kostova et al., 2002). The cysteine 
residues in Keap1 are all reactive but there are 4 in particular in the IVR, which 
demonstrate the highest reactivity to compounds, such as sulforaphane (Dinkova-Kostova 
et al., 2002). The Neh2 domain of Nrf2 does not contain cysteine residues that are acted 
upon by inducers (Dinkova-Kostova et al., 2002). Inducers may react with the sulfhydryls 
in the IVR on Keap 1, changing the conformation of Keap 1, and releasing Nrf2. Cysteine 
reactivity is one of the mechanisms whereby Nrf2 is released. Kinases may also play a 
role in a phosphorylation event that results in Nrf2 release from Keap1.  
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            Figure 2.8. A schematic of Keap1. 
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 Classical MAPK signalling involves phosphate additions through a 3 tiered 
cascade consisting of mitogen activated kinase kinase kinase (MAPKKK) (transforming 
growth factor-β activated kinase-1 (TAK1), apoptosis signal-regulating kinase 1(ASK1), 
Raf and MAPK/extracellular signal-regulated kinase kinase (MEKK1) to mitogen 
activated kinase kinase (MAPKK) (MAPKK 1-7 and MEK 1-5), and lastly to MAPK 
(p38, c-Jun NH2-terminal kinase (JNK) and extracellular signal regulated kinase (ERK)), 
(See figure 2.9) (Kyriakis and Avruch, 2001). Examples of some other kinases that are 
not in this 3 tiered cascade include protein kinase C (PKC) and phosphatidylinositol 3-
kinase (PI3K). It is important to keep in mind that MAPKs in different tiers do not 
always signal to the same downstream kinase. Instead, upstream kinases add phosphate 
groups onto an array of other downstream kinases. This introduces a tiered cascade that is 
not necessarily linear and therefore activation of a specific kinase will not always elicit 
the same response. MAPKKK 
(TAK1, ASK1, RAF, MEKK1) 
 
 
MAPKK  
(MKK 3/6, MEK5, MEK1/2, MKK4/7)
 
 
MAPK  
(p38, Erk1/2 JNK) 
 
 
 
 
                          Figure 2.9. A schematic of the tiered MAPK families. 
Some kinases, such as ASK1, are associated with phosphatases. ASK1 is bound to 
protein phosphatase 5 (PP5) and Trx in the cytosol (Morita et al., 2001). The redox 
sensor, Trx along with PP5, regulate ASK1 activity. Therefore kinase activation is 
dependant on other factors such as phosphatases. The regulation of kinases is complex 
and depends on the conditions at the time of activation. For example, ASK1 can be 
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activated to induce apoptosis (Morita et al., 2001) and/or phase 2 enzymes (Yu et al., 
2000). This adds to the complexity of finding consistent themes in the literature that 
explain Nrf2 activation.  
Several kinases have been implicated in Nrf2 activation, namely: MEKK1, 
TAK1, ASK1, JNK, ERK2, p38, phosphatidylinositol 3-kinase (PI3K), and protein 
kinase C (PKC). In HepG2 cells treated with tBHQ (100 µM), sodium arsenite and 
mercury chloride, MEKK1, TAK1 and ASK1, were activated (Yu et al., 2000). These 
kinases were thought to act via MKK4 and MKK6 to induce the ARE (Yu et al., 2000c). 
In human epithelial cancer cells (HeLa) and HepG2 cells the MEK inhibitor, PD98059, 
prevented Erk2 activation of the ARE but did not affect JNK activation induced by tBHQ 
(500 µM) and butylated hydroxyanisole (BHA) (250 µM) (Yu et al., 1997). In human and 
mouse hepatoma cells, tBHQ (50-100 µM) and Sul (12.5-50 µM) activates ARE reporter 
activity, via Erk2 and not JNK (Yu et al., 1999). Oxidative stress activates MEKK2 and 
this led to the activation of ERK2, but not JNK (Yu et al., 1997). These studies suggest 
that tBHQ may act via MEKK to activate Erk2 and induce phase 2 enzymes. The role of 
JNK is not clear. 
 p38 MAPK can either negatively regulate the ARE or have no effect on it. In 
HepG2 and in murine hepatoma Hepa1c1c7, inhibition of p38 resulted in greater QR 
activity, in the presence of tBHQ (Yu et al., 2000b). It appears that p38 negatively 
regulates the ARE (Yu et al., 2000b). Conversely, in HepG2 cells that were treated with 
phorbol 12-myristate 13 acetate (PMA), inhibition of MEK and p38 kinases had no effect 
on ARE reporter activity (Huang et al., 2000). In H4IIE cells, a rat hepatoma cell line, 
which was administered tBHQ, Erk negatively regulates the ARE whereas p38 MAP 
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kinase and JNK had no effect on phase 2 enzyme induction (Kang et al., 2001). This 
suggests that in the same cell type, different inducers may signal through different 
pathways; in different cell types, the same inducer may signal via different pathways.   
PI3K may contribute to Nrf2 translocation possibly by acting through the 
cytoskeleton. PI3K has an implicated role in microfilament assembly, and the 
translocation of actin proteins (Kang et al., 2002). PI3K is thought to play a role in Nrf2 
activation. H4IIE cells were examined to look at the effects of tBHQ on phase 2 enzyme 
induction, with an emphasis on the role of MAPK and PI3K (Kang et al., 2001). 
Activation of PI3K resulted in GST induction (Kang et al., 2001), Nrf2 translocation to 
the nucleus and increases in the amount of nuclear actin (Kang et al., 2002). 
Administration of cytochalasin B that disrupts actin resulted in Nrf2 translocation, 
whereas phalladoin, which prevents actin breakdown, prevented Nrf2 translocation into 
the nucleus (Kang et al., 2002). Administration of Wortmannin, which inhibits PI3K, 
prevented all of these changes from happening (Kang et al., 2002)(Kang et al., 2001). 
PI3K may contribute to Nrf2 translocation possibly by acting through the cytoskeleton. 
Sites that can be phosphorylated by PKC have been found on both Keap 1 and in 
the Neh2 domain of Nrf2. PKC is thought to increase ARE activity. Huang and his 
colleagues have shown that if Ser 40 on the Neh2 domain is mutated to alanine, Keap 1 
will still interact with Nrf2. However, in the presence of the PKC inhibitor staurosporine, 
there was a decrease in the amount of ARE activity (Huang et al., 2002). Huang et al 
conclude that Nrf2 is phosphorylated by PKC, released from Keap 1 and then shuttled to 
the nucleus. It is possible that this regulatory step is required for ARE activation. In 
HepG2 cells, PMA was able to activate the ARE (Huang et al., 2000). Staurosporine and 
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Ro-320432, inhibitors of PKC prevented PMA activation of the ARE (Huang et al., 
2000). Therefore, PKC phosphorylation appears to increase ARE activity. The role 
played by various kinases in signalling is unclear (See figure 2.10). This is not surprising 
given that inducers may be working within a very complex communication network of 
kinases and phosphatases. The effect of inducers may depend on several factors such as 
the type of inducer, the cell type, and the state that the cell is in i.e. proliferating or not 
(Owuor and Kong, 2002) and perhaps the basal level of oxidative stress that is present.   
2.2.2.2.2.3 Nrf2 and phase 2 enzymes 
Several studies have demonstrated that Nrf2 deficient animals are not able to 
withstand certain xenobiotics. For example, Nrf2 deficient mice are more susceptible 
than wild type mice to gastric neoplasia after administration of the carcinogen, benzo [a] 
pyrene (Ramos-Gomez et al., 2001). Also, in Nrf2 wild type mice, BHT results in 
temporary lung damage, by destroying alveoli type 1 epithelial cells. Seven days later, the 
lungs appear normal again. Nrf2 deficient mice died from doses of BHT that were well 
tolerated in wild type mice (Chan et al., 2001). BHT metabolites are not lethal in Nrf2 
wild type mice. It is proposed that BHT depletes GSH, thereby damaging the lungs. The 
lungs have lower levels of GSH and were more susceptible to BHT damage, compared to 
the liver, which contains higher levels of GSH (Mizutani et al., 1987). Given that phase 2 
enzymes contribute to elevating GSH concentrations, then the inability of Nrf2 deficient 
mice to upregulate phase 2 enzymes may explain their inability to withstand xenobiotics. 
N-acetyl cysteine (NAC), a GSH promoting compound, decreased the mortality of Nrf2 
deficient mice who were administered with acetaminophen (Chan et al., 2001). In Nrf2 
deficient mice, constitutive levels of GST and QR were reduced by 50-80% (Ramos-
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Gomez et al., 2001). Unlike in Nrf2 wild type mice, when the phase 2 enzyme inducer 
oltipraz was given to Nrf2 deficient mice, their incidence of benzo [a] pyrene induced 
gastric tumours was not decreased. These studies provide evidence that Nrf2 plays a role 
in phase 2 enzyme induction.  
A direct link between Sul and an Nrf2 mediated mechanism of phase 2 enzyme 
induction is evidenced in studies by Thimmulappa (2002) and Morimitsu (2002). 
Thimmulappa (2002), shows that Sul acts via Nrf-2 to induce phase 2 enzymes such as 
GST mu, alpha 1,2,and 3, γ-glutamylcysteine ligase regulatory and catalytic subunits in 
rat liver. Morimitsu (2002) demonstrates that in the small intestine of mice the 
administration of Sul induces phase 2 enzymes via Nrf2.  
2.2.2.2.3  Sulforaphane and NF-κB 
 
Phase 2 enzymes are not solely under the regulation of Nrf2. A study by Hayes 
(2000), demonstrates that ethoxyquin, a bird food preservative, increases the levels of 
several GST isoforms in wild type mice (as reviewed in Hayes et al., 2000). In Nrf2 
deficient mice, GST expression is still present, suggesting that GST expression is not 
solely dependent on Nrf2 (as referenced in Hayes et al., 2000). Some genes have an ARE 
and/or NF-κB elements in their promoter regions that are responsible for phase 2 enzyme 
induction. Ishii et al. (2000) examined peritoneal macrophages from Nrf2 deficient mice. 
In the wild type mice, Nrf2 was shown to regulate genes such as heme oxygenase-1 (Ishii 
et al., 2000) that play a role in decreasing levels of oxidative stress. Immunoblot analysis 
in this study demonstrated that different inducers failed to induce heme oxygenase-1 in 
the Nrf2 deficient mice (Ishii et al., 2000). The inducer menadione slightly increased 
heme oxygenase-1 and the cystine transporter, which was thought to occur via NF-κB 
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(Ishii et al., 2000). Heme oxygenase-1 and the cystine transporter have NF-κB elements 
in their promoter regions and menadione has the ability to activate NF-κB (Ishii et al., 
2000). This study demonstrates that Nrf2 is required for the activation of the ARE whilst 
oxidative stress may be sufficient for NF-κB activation resulting in phase 2 enzyme 
induction (See figure 2.10).  
In terms of a link between Sul and NF-κB, it has been shown that during 
lipopolysaccharide induced oxidative stress in cultured macrophages, Sul prevented DNA 
binding of NF-κB, reducing the amount of inducible nitric oxide synthase and 
cycloxygenase 2 protein (Heiss et al., 2001). During oxidative stress, Sul may increase 
phase 2 enzymes and by causing a more reduced environment, indirectly affect the 
binding of transcription factors such as NF-κB (See figure 2.10). Alternatively, Sul may 
directly affect NF-κB signalling pathways.  
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Figure 2.10. A proposed mechanism of phase 2 enzyme induction 
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2.2.2.2 Phase 1 enzymes 
The protective effects of Sul may also be due to its inhibition of phase 1 enzymes. 
Amongst the family of enzymes that comprise phase 1 enzymes are the cytochrome P450 
family which are found in the liver, gastrointestinal tract, lung and kidneys (as reviewed 
in Rushmore and Kong, 2002).  
Polycyclic aromatic hydrocarbons, heterocyclic amines and nitrosamines are 
dietary carcinogens that when activated by phase 1 enzymes damage DNA (Steinkellner 
et al., 2001). Phase 1 enzymes are selectively inhibited and this inhibition is 
chemoprotective (Zhang and Talalay, 1998). In Salmonella typhimurium strain TA100 
and T-antigen immortalized human liver epithelial cells, concentrations of Sul from 
0.064-20 µmol/L inhibited N-nitrosodimethylamine induced unscheduled DNA synthesis 
via the inhibition of CYP2E1 (Barcelo et al., 1996; Barcelo et al., 1998) (Barcelo et al., 
1998). Concentrations of Sul ranging from 0-40 µM were shown to inhibit several 
members of the human cytochrome family in E. coli membranes that express these 
human cytrochromes (Langouet et al., 2000).  
2.2.2.3  Cell cycle arrest and Apoptosis 
 
The protective actions of Sul may also be attributed to cell cycle arrest and or 
apoptosis. Concentrations of Sul ranging from 3-50 µM in human prostrate cells and in 
quiescent human colon carcinoma cells resulted in cell cycle arrest and apoptosis (Chiao 
et al., 2002; Gamet-Payrastre et al., 2000). Similar effects of Sul (concentration range of 
3- 30 uM), were obtained in human T-cell leukemia cells by (Fimognari et al., 2002).  
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Inducers can be chemoprotective in that they promote apoptosis and/or 
detoxification (Kirlin et al., 1999). In human colon carcinoma cell line (HT29), 
administration of the phase 2 enzyme inducers, benzyl isothiocyanates, allyl sulfide, 
dimethyl fumarate, BHA, gave rise to an increase in phase 2 enzymes as well as to the 
activation of apoptosis (Kirlin et al., 1999). Kirlin points out that phase 2 enzyme 
induction and apoptosis may not be mechanistically linked together (Kirlin et al., 1999).  
Mechanisms of protection by Sul are still not clear. Phase 2 enzyme induction, 
phase 1 enzyme inhibition, cell cycle arrest and apoptosis are all possible mechanisms of 
actions that may act in concert with each other or alone, depending on the context of 
administration. This study aims to explore Sul’s effect on parameters of oxidative stress 
and inflammation in the blood and phase 2 enzyme induction in the liver of both male 
and female SHRsp.  
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Chapter 3 Materials and Methods 
3.1 Source of Experimental Animals 
SHRsp were initially obtained from the National Institute of Health and colonies 
were then bred by the College of Medicine Animal Facilities at the University of 
Saskatchewan. As it was not possible to acquire a sufficient number of rats for each 
experimental group at one time point, rats were collected as subsets over time, running 
from April 2002 to February 2003. Data were collected from a total of 5 subsets of 
animals. Tissue from the first and second subsets of animals was discarded as the timer 
that regulates the light switch to allow for 12 hour dark/12 hour light cycles was not 
functioning properly. The third and fourth subsets of animals were male SHRsp and the 
fifth subset was female SHRsp. 
3.2 Source of diet and sprouts  
The diet fed was purified 1993 Growth diet of the American Institute of Nutrition 
(AIN-93G) modified to contain no added antioxidant (tBHQ) (See Table 3.1) (Reeves et 
al., 1993).  
Broccoli seeds (H6458) were obtained from Mumms Seeds and Sprouting 
(Shellbrook, Saskatoon, SK, Canada). These seeds were kept in a 10 % bleach solution 
for 10 minutes, washed and kept out of light for 3 days. The sprouted seeds were 
maintained in light and grown for 3 days after which time they were air dried for 7 days 
and were ready for usage. Analysis of these dried broccoli sprouts shows that they 
contain 27.3 µmols of sulforaphane per gram of sprouts (Wu et al., 2004).  
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Table 3.1 Composition of Experimental Diet1 
Components   g/kg diet 
Casein 200 
Cornstarch 397.5 
Dyetrose2 132 
Sucrose 100 
Cellulose 50 
Soybean Oil 70 
Salt Mix3 35 
Sodium Bicarbonate 6.4 
Vitamin Mix4 10 
Choline Bitartrate 2.5 
L-Cystine 3 
1Diets were purchased from Dyets Inc. (Bethlehem, Pennsylvania, US). 
2Dyetrose (dextrinized cornstarch) 
3Salt mix supplied the following minerals (g/kg mix): calcium carbonate 357.0, monobasic potassium phosphate 196.0, 
potassium citrate·H2O 70.78, sodium chloride 74.0, potassium sulfate 46.6, magnesium oxide 24.0, ferric citrate 6.06, 
zinc carbonate 1.65, manganous carbonate 0.63, cupric carbonate 0.3, potassium iodate 0.01, sodium selenate 0.01025, 
ammonium paramolybdate·4H2O 0.00795, sodium metasilicate·9H2O 1.45, chromium potassium sulfate·12H2O 0.275, 
lithium chloride 0.0174, boric acid 0.0815, sodium fluoride 0.0635, nickel carbonate 0.0318, ammonium vanadate 
0.0066, finely powdered sucrose 221.026.  
4Vitamin mix supplied the following vitamins (g/kg mix): niacin 3.0, calcium pantothenate 1.6, pyridoxine·HCl 0.7, 
thiamine·HCl 0.6, riboflavin 0.6, folic acid 0.2, biotin 0.02, vitamin E acetate (500 IU/g) 15.0, vitamin B12 (0.1%) 2.5, 
vitamin A palmitate (500,000 IU/g) 0.8, vitamin D3 (400,000 IU/g) 0.25, Vitamin K1/dextrose mix (10mg/g mix) 7.5, 
sucrose 967.23.  
 
 
3.3 Experiment 1 
Objective: To determine if ITCs from broccoli sprouts are detectable in the plasma of 
SHRsp.  
3.3.1 Experimental Design 
Male SHRsp were housed individually throughout the study in plastic shoebox 
cages in a room with a 12-hour light/dark cycle. Animals were handled daily and their 
weights were recorded on a weekly basis. Until 2 months of age SHRsp were fed 
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standard rat chow (Purina). At 2 months of age all SHRsp were changed to a modified 
AIN-93G diet (See Table 3.1). The rats were then also assigned to 1 of 2 groups. 
 
One group of animals (n=5) was fed 200 mg of dried broccoli sprouts per day and 
the other group (control group) (n=7) did not receive broccoli sprouts. This feeding 
regime lasted for 3 months during which time SHRsp had free access to tap water.  
At the end of the feeding trial, the rats were anaesthetized with halothane and 
blood was collected from the left ventricle in a lithium-heparinized vacutainer. Blood was 
centrifuged for 10 minutes at 1500 x g and stored at –70 °C until it was analyzed in Dr. 
Paul Talalay’s laboratory at John Hopkins University. A cyclocondensation assay was 
performed followed by high performance liquid chromatography to determine levels of 
dithiocarbamates (DTC) as described by (Liebes et al., 2001). DTC are indicative of ITC 
absorption. 
 
3.3.2 Principle of the cyclocondensation assay and high performance liquid 
chromatography   
During the cyclocondensation assay ITC reacts with 1,2-benzene-dithiol giving 
rise to 1,3-benzenedithiol-2-thione. This product is then assayed by reverse phase high 
performance liquid chromatography and detected at 365 nm by an ultra-violet photodiode 
array detector.  
3.3.3 Statistics 
 
Data were analysed using independent 2 tailed t-tests on SPSS software version 
11.0. Statistical significance was set at p < 0.05.  
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3.4 Experiment 2 
Objective: To determine if the daily feeding of 200 mg of dried broccoli sprouts to male 
and female SHRsp reduces oxidative stress as reflected by an increase in concentrations 
of plasma protein thiols and blood GSH. 
3.4.1 Experimental Design 
 
Male (n=13 for the Control group and n=14 for the Broccoli group) and female 
(n=10 for the Control group and n=11 for the Broccoli group) SHRsp were used and 
treated as described in Experiment 1. Blood collection for the protein thiol assay was also 
the same as in Experiment 1 but differed for the blood GSH assay. For the latter, whole 
blood was added to an equal amount of 30% trichloroacetic acid containing 2% 
ethylenediaminetetraacetate (EDTA), centrifuged at 15000 x g for 5 minutes and the 
supernatant fluid snap frozen in liquid nitrogen and stored at –70 °C until assayed. 
Concentrations of blood GSH and plasma protein thiols are measures of oxidative stress 
(Asensi et al., 1999; Hu, 1994). 
3.4.1.1 Blood GSH 
 
3.4.1.1.1 Principle of the blood GSH assay  
 
Blood GSH concentration was determined as per the method of Asensi et al. 
(1999), which uses chlorodinitrobenzene (CDNB). GST catalyses the formation of S- 
(2,4-dinitrophenyl) glutathione adduct from CDNB and GSH. This adduct can be 
detected spectrophotometrically (SPECTRA max³ 190, Sunyvale, CA) at 340 nm (Habig 
and Jakoby, 1981).  
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 3.4.1.1.2 Preparation of reagents 
 
  A 0.5 M potassium phosphate buffer, with a pH of 7.00, containing 1 mM EDTA, 
was made up of 0.1746 mols potassium dihydrogen phosphate (KH2PO4) and 0.3253 
mols of dipotassium hydrogen phosphate (K2HPO4) to 1 L of deionized distilled water 
(ddH2O). The GST (500 U/ml) solution was made by adding 7 mg of stock GST (71 
U/mg) in 1 ml of phosphate buffer. The CDNB solution (2 mg/ml) was made in ethanol 
and incubated at 37°C for 20 minutes to dissolve. The trichloroacetic acid solution (30%) 
was made by bringing 30 g of trichloroacetic acid (0.0744g of EDTA) to a volume of 100 
ml of ddH2O. The GSH stock solution (3.48 mM) was made by brining  10.7 mg of GSH  
to a final volume of 10 ml of 15% trichloroacetic acid containing 1 mM of EDTA. 
3.4.1.1.3 GSH assay 
 
A GSH standard curve was set up with a blank and concentrations of GSH 
including 6.25 µM, 12.5 µM, 25 µM, 50 µM and 100 µM that were diluted from the GSH 
stock (3.48 mM) in potassium phosphate buffer. To an eppendorf tube, 825 µl of 
potassium phosphate buffer, 25 µl of each respective standard, and 10 µl of CDNB were 
added. The contents were vortexed and 240 µl was pipetted into each microtitre well. To 
each microtitre well except for the one containing the blank, 10 µl of GST was then 
added. The blank was made up by adding 239.9 µl of buffer, 7.2 µl of 100 µM GSH, 2.9 
µl of CDNB to an eppendorf tube and vortexing them and pipetting 240 µl of this mixture 
into a microtitre plate well. After 5 minutes, the optical density was read at 340 nm as an 
endpoint reaction. The concentration of each standard was derived according to the Beer-
Lambert law using the extinction coefficient of CDNB (9600M-1cm-1) (Lehninger, 1993). 
Blood samples were assayed as per the procedure described for the standards. Samples 
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were run in triplicate. The concentrations of the samples were obtained using linear 
regression and interpolation from the standard curve. 
3.4.1.2. Plasma Protein Thiols 
 
3.4.1.2.1 Principle of the plasma protein thiol assay 
 
Levels of protein thiols were determined as described by Hu, (1994). In the presence 
of 5, 5’-dithiobis(2-nitrobenzoic acid) (DTNB), thiols give rise to the formation of 2, 5’-
thionitrobenzoic acid (TNB). TNB can then be assayed spectrophotometrically at 412 
nm.       
3.4.1.2.2 Preparation of reagents 
A DTNB (10 mM) solution was made up by bringing 4 mg of DTNB to a final 
volume of 1 ml of absolute ethanol. A Tris (0.25 M) buffer with EDTA (20 mM) was 
made up by bringing 30.275 g of Tris base to a final volume of 1 L of ddH2O with 40 ml 
of an EDTA stock solution (0.5 M), pH 8.2. A GSH stock solution (.02 mM) for making 
up the standards was made up by bringing 0.06 g of GSH to a final volume of 10 ml of 
ddH2O and stored at –20°C.    
3.4.1.2.3 Plasma protein thiol assay 
 
GSH standards ranged in concentration from 15.62 µM, 31.25 µM, 62.5 µM, 125 
µM, 250 µM, 500 µM, and 1000 µM. Standards were made up from the GSH stock 
solution (1 mM) and diluted in Tris-EDTA buffer. To a microtitre plate well, 10 µl of 
GSH standard was added to 200 µl of Tris-EDTA. A reading (A1) was taken at 412 nm. 
Then, 4 µl of DTNB was added in and the plate was incubated at room temperature for 15 
minutes. Another reading (A2) was taken at 412 nm. A DTNB blank (B) was used 
containing 210 µl of Tris-EDTA buffer and 4 µl of DTNB. The total sulfhydryl groups 
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were determined as described in Hu (1999). The molar absorption coefficient for TNB is 
13600 cm-1M-1. 
(A2-A1-B) X (0.2/0.01) 13.6 = (A2-A1-B) X 1.57 mM. 
 Samples were assayed in triplicate using the same procedure as the standards.  
3.4.1.2.4 Protein concentration 
To determine the amount of plasma protein present a bicinchoninic acid (BCA) 
assay was performed as described by Smith et al., (1985) using bovine serum albumin 
(BSA) as the reference protein. Standards were made up to concentrations of 0.0625 
mg/ml, 0.125 mg/ml, 0.25 mg/ml, 0.5 mg/ml and 1 mg/ml using a Tris-EDTA buffer. The 
1 mg/ml standard was stored at –70 °C. Working BCA solution was made up with BCA 
and copper sulfate (1:50). To each microtitre well 10 µl of standard or sample was added 
with 100 µl of working solution. Standards and samples were run in triplicate. The 
microtitre plate was incubated at 37°C for 30 minutes and then read at 562 nm by a 
microplate spectrophotometer (Spectra max 190) with SOFT max pro software version 
4.0. Protein concentrations of the samples were calculated by linear regression from the 
standard curve. 
3.4.2 Statistics  
  
Data for blood GSH and plasma protein thiols were analyzed on SPSS software 
version 11.0. using an unpaired two tailed t-test. Statistical significance was set at p < 
0.05.    
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3.5 Experiment 3 
Objective: To determine if the daily feeding of 200 mg of dried broccoli sprouts to male 
and female SHRsp reduced parameters of the acute phase response as reflected by a 
decrease in plasma ceruloplasmin and an increase in plasma albumin concentration. 
3.5.1 Experimental Design 
Male (n=13 for Control group and n=14 for the Broccoli group) and female (n=10 
for the Control group and n=11 for the Broccoli group) SHRsp were used and treated as 
described in Experiment 1. 
3.5.1.1 Ceruloplasmin 
 
3.5.1.1.1 Principles of Western blotting 
 
Western blotting was used to determine levels of plasma CP in male and female 
SHRsp. A 12 % sodium dodecyl sulfate (SDS) gel was prepared as described by 
Sambrook et al. (1989), and 20 µg of proteins were electrophoresed. The protein was then 
transferred to a nitrocellulose membrane and detected with a mouse monoclonal CP 
antibody (1:750 dilution) (Transduction Laboratories). The secondary antibody used was 
peroxidase- labeled anti-mouse IgG (1:4000 dilution) (Sigma). Chemiluminescence 
detection of the proteins was performed using the NEN™ Renaissance Western Blot 
Chemilluminescence Reagent (NEN™ Life Sciences Products) followed by 
autoradiography.  
3.5.1.1.2 Preparation of reagents  
Loading buffer was made up by adding 1 ml of glycerol, 2 ml of 10% SDS, 0.25 
mg of bromophenol blue, 1.25 ml of 0.5M Tris buffer (pH 6.8) and 4.25 ml of ddH20. To 
950 µL of loading buffer was added 20 µL of β-mercaptoethanol (1/20 v/v). Acrylamide 
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solution was made up by adding 30.0 g of acrylamide and 0.8 g of bisacrylamide to a 
final volume of 100 ml ddH20. Running buffer ( pH 8.5) was made up by adding 24.0 g 
of Tris, 115.2 g of glycine, 8.0 g of SDS to a final volume of 8.0 L ddH20. Tris buffer 
(1M, pH 6.8) was made up of 31.5 g in 200 ml of ddH20. Tris buffer (1.5M, pH 8.8) was 
made up of 36.3 g in a total volume of 200 ml of ddH20. Stacking buffer was made up of 
4.1 ml of ddH2O, 1.0 ml of 30% acrylamide, 0.75 ml of 1.0 M Tris (pH 6.8), 0.06 ml of 
10 % SDS, 10% of ammonium persulfate (w/v) in ddH2O, and 0.006 ml of TEMED. 
Separating buffer (12%) was made up of 6.6 ml of ddH2O, 8.0 ml of 30 % acrylamide, 5 
ml of 1.5 M Tris (pH 8.8), 0.2 ml of 10 % SDS, 0.2 ml of 10 % ammonium persulfate, 
and 0.008 ml of TEMED. Transfer buffer was made up by adding 12.0 g of Tris, 56.4 g 
of glycine, 4.0 g of SDS, 800 ml of methanol (the methanol was added in after the 
contents was dissolved in ddH2O), and brought to a final volume of 4.0 L. The transfer 
buffer was stored at 4°C. Phosphate buffered saline (PBS) (pH 7.2-7.5) was made up by 
adding 26.0 g of monobasic sodium phosphate (NaH2PO4)-H2O, 115.0 g of dibasic 
sodium phosphate (Na2HPO4), and 85.0 g of NaCl to a final volume of 10.0 L of ddH2O. 
PBST was made up by adding 0.5% of TWEEN 20 to PBS. Skim milk (5%) was made up 
by bringing 5 g of skim milk to a final volume of 100 ml of ddH20 or for a 2.5 % 
solution, 2.5 g of skim milk was brought up to a final volume of 100 ml of ddH20. 
3.5.1.1.3 Protein concentration 
Protein concentration was determined as described in section 3.4.1.2.4 except 
standards and samples were made up in 0.1 M potassium phosphate buffer. 
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3.5.1.1.4 Tissue preparation 
 The amount of protein was determined and 20 µg of each sample was pipetted 
into an eppendorf tube. To this 4 times the volume of acetone was added for 10 minutes 
at –20°C. Samples were then centrifuged at 16250 x g for 10 minutes after which time the 
acetone was removed and the pellets were allowed to air dry for about 20 minutes. 
Loading buffer at a concentration of 1 µL per µg of protein was added to the pellets, 
boiled for 5 minutes and then loaded onto the gel. A reference marker was also used and 
was boiled along with the samples, and 15 ul of it was loaded onto the gel. 
3.5.1.1.5 Western blot  
The resolving gel was poured between the glass plates of the western blotting 
apparatus. When it was set the stacking gel was poured in and the well comb was placed 
between the plates. When the gel was polymerized the samples were loaded and the gels 
were placed into the gel tank with running buffer. The gel was run for 30-34 minutes at 
200V until the dye front approached the bottom of the gels. The gels along with some 
filter paper were placed in transfer buffer for 10 minutes. The gels were then sandwiched 
between filter paper and transferred at 13 V for 1 hour onto nitrocellulose membrane 
using the Trans-Blot SD Semi-dry Transfer Cell (Biorad). The membranes were then 
blocked in 2.5% skim milk for 1 hour. They were then incubated in primary antibody 
diluted in 2.5% milk for 1 hour at room temperature, followed by the secondary antibody 
(diluted in 5% milk) and incubated for 1 hour. The blots were then washed 3 times by 15 
minutes in 2.5 % milk, followed by three 10 minute washes in PBST. The blots were then 
placed in chemiluminescence solution for 1 minute, placed into a cassette and exposed to 
a Kodak x-ray film for about 1 minute and the film developed. Band densities were then 
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scanned and blot densitometry was performed using Scion Image software. The band 
density for the control group was arbitrarily set at 100% and the band density for the 
broccoli fed-group was expressed relative to that of the control group.  
3.5.1.2 Plasma albumin 
3.5.1.2.1 Principle of the Albumin assay 
 
Albumin levels were detected as described by Rodkey (1965). Bromcresol green 
has an absorbance maximum at 615 nm. Albumin binds to bromcresol green forming an 
albumin- bromcresol green complex. A decrease in optical density readings is reflective 
of the presence of albumin.  
3.5.1.2.2 Preparation of reagents 
Bromcresol green solution (0.6 mM) was made up by bringing 0.432 g of the 
sodium salt of bromcresol green to a final volume of 1 L of ddH2O. A buffer indicator 
solution is made up by bringing 2.65 g of KH2PO4 and 4.33 g of Na2HPO4 to a volume of 
500 ml of ddH2O, then adding in 75 ml of bromcresol green stock solution and bringing 
the volume to 1L. Albumin standards were made up to concentrations of 6.25 mg/ml, 
12.5 mg/ml, 25 mg/ml, 50mg/ml and 100 mg/ml.    
3.5.1.2.3 Plasma albumin assay 
A nonprotein standard (blank) was made up by adding 1.5 ml of indicator solution 
to 10 µl of ddH2O. Standards were made by adding 10 µl of the respective standard to 1.5 
ml of indicator solution. Eppendorf tubes were vortexed to mix, and 250 µl was placed in 
each microtitre well and run in triplicate. Readings were taken at 615 nm using the 
microtitre plate and reader and software as described above. Samples were assayed in 
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triplicate as per the procedure for the standards. Concentrations were obtained by using 
linear regression. 
3.5.2 Statistics 
Within the respective male and female SHRsp rat sets, samples were analyzed 
using unpaired 2 tailed t-tests on SPSS.   
Experiment 4 
Objective: To determine if 200 mg of broccoli sprouts induces phase 2 enzymes in the 
livers of SHRsp as shown by an increase in glutathione reductase (GR), glutathione-S-
transferase (GST), and quinone reductase (QR) activity. 
3.6.1 Experimental Design 
Male (n=13 for Control group and n=14 for the Broccoli group) and female (n=10 
for the Control group and n=11 for the Broccoli group) SHRsp were placed into either a 
control group or a broccoli group as described in Experiment 1 and kept on their feeding 
regime until they were 5 months of age. Male Sprague Dawley (SD) rats (n=3 per group) 
were also used and treated like the SHRsp with the exception that they were perfused at 6 
months of age. SD were used to collect preliminary information as a control animal for 
the SHRsp. They were obtained from Charles River Laboratories, St Constant, Quebec, 
Canada. SHRsp and SD were anesthetized with halothane and perfused transcardially 
with 0.03 M PBS and 2500 U/L of heparin after blood was collected. Livers were 
collected and immediately snap frozen in liquid nitrogen and stored at –70 °C. The frozen 
tissue was ground with a homogeniser (Mickro-Dismembrator, B, Braun Biotech 
International GmBH) for 4 x 1 min at a frequency of 3000 oscillations per minute and 
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stored at –70 °C until assayed for GR, GST and QR activity. The activity of these 
enzymes is used as an indicator of phase 2 enzyme induction (Staack et al., 1998). 
3.6.1.1 Glutathione Reductase 
3.6.1.1.1 Principle of the Glutathione Reductase assay  
GR was detected as described by (Carlberg and Mannervik, 1975). GR catalyses 
the reduction of oxidized GSH using NADPH as the electron donor. The disappearance 
of NADPH is detected spectrophotometrically at 340 nm.   
3.6.1.1.2 Preparation of reagents 
Incubation buffer consisting of 0.1 M sodium phosphate buffer (pH 7.6) contained 
0.5 mM EDTA and was made up by adding 13 ml of 0.1 M NaH2PO4 buffer , 87 ml of 
0.1 M of Na2HPO4 buffer and 0.01861 g of EDTA. A 0.1 M of NaHPO4 buffer was made 
up by bringing13.8 g of NaH2PO4 buffer up to a final volume of 1 L of ddH2O. A 0.1 M 
NaH2PO4 buffer was made up by bringing 14.2 g of Na2HPO4 buffer up to a final volume 
of 1 L of ddH2O. A 1 mM NADPH solution was made by dissolving 0.8 mg of NADPH 
up to 1 ml of 0.1 % sodium bicarbonate (NaHCO3)(pH 9). A 10 mM solution of oxidized 
GSH (GSSG) was made up by bringing 6.6 mg of GSSG to a final volume of 10 ml of 
incubation buffer.   
3.6.1.1.3 Tissue preparation 
Frozen liver tissue was ground with a homogeniser (Mickro-Dismembrator, B, 
Braun Biotech International GmBH) for 4 x 1 min at a frequency of 3000 oscillations per 
minute and stored at–80 C until assayed. Liver tissue was diluted in incubation buffer 
(1:100 dilution). Tissue was centrifuged for 10 minutes at 16250 x g. Samples were then 
 55
  
sonicated 3 times for 5 seconds on the Sonifier Cell Disruptor (Model W140 from 
Ultrasonics, Inc.).  
3.6.1.1.4 NADPH standard curve 
NADPH standards were made up by diluting the stock solution into 
concentrations of 1 nM, 5 nM, 10 nM and 15 nM. To a microtitre plate, 300 µl of 
standard was added in triplicate and read at 340 nm.  
3.6.1.1.5 Kinetic assay 
  To each microtitre well, 140 µl of incubation buffer, 30 µl of 1mM NADPH and 
100 µl of sample were added. The microtitre plate was incubated for 10 minutes at room 
temperature and 10 µl of GSSG was added. Readings were taken with the same plate 
reader and software as described above at 340 nm in 30 second intervals for 4 minutes. 
Data were collected using SOFTmax³PRO software version 4.0.  
3.6.1.1.6 Protein concentration 
Protein concentration was determined as described in section 3.4.1.2.4 except 
standards and samples were made up in incubation buffer. 
3.6.1.2 Glutathione-S-transferase 
3.6.1.2.1 Principle of the GST assay     
GST was detected as described by (Habig and Jakoby, 1981). Glutathione 
transferase catalyses the formation of S-(2,4-dinitrophenyl) glutathione adduct from 
CDNB and GSH. This adduct can be detected spectrophotometrically at 340 nm.  
3.6.1.2.2 Preparation of reagents 
A 0.1 M potassium phosphate buffer (pH 6.5) was made by bringing 0.0659 mols 
of KH2PO4 and 0.034 mols of K2HPO4 to a final volume of 1 L with ddH2O. A 25 mM 
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CDNB solution was made by bringing 0.05168 g of CDNB to a final volume of 10 ml of 
ethanol. A 10 mM GSH solution was made up by bringing 15.68 mg of GSH to a final 
volume of 5 ml of buffer. 
3.6.1.2.3 Tissue preparation 
Frozen liver tissue was ground with a homogeniser (Mickro-Dismembrator, B, 
Braun Biotech International GmBH) for 4 x 1 min at a frequency of 3,000 oscillations per 
minute and stored at–80 C until assayed. Liver tissue was diluted in 1.0 M potassium 
phosphate buffer (pH 6.5) (1:100 dilution). Samples were then sonicated 3 times for 5 
seconds and then centrifuged for 10 minutes at 16250 x g.  
3.6.1.2.4 Kinetic assay 
To each well was added 10 µl of sample, 195 µl of phosphate buffer and 25 µl of 
10 mM GSH. This mixture was kept at room temperature for 15 minutes and then 20 µl 
of 12.5 mM CDNB was added. Readings were taken kinetically at 340 nm every 30 
seconds for 5 minutes. 
3.6.1.2.5 Protein concentration 
Protein concentration was determined as described in section 3.4.1.2.4 except 
standards and samples were made up in 0.1 M potassium phosphate buffer. 
3.6.1.3 Quinone Reductase 
3.6.1.3.1 Principle of the QR assay 
QR was assayed as described by (Prochaska and Santamaria, 1988). The quinone 
menadione is reduced to menadiol using NADPH as the electron donor. Menadiol then is 
reduced into 3-(4, 5-dimethylthiazo-2-yl)-2, 5- diphenyltetrazolium bromide (MTT) that 
can be detected spectrophotometrically at 610 nm. 
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3.6.1.3.2 Preparation of reagents 
A 50 mM Tris buffer (pH 7.4) was made and stored at room temperature by 
bringing 661 mg of Trizma –hydrogen chloride and 97 mg of Trizma base up to a final 
volume of 100 ml of ddH2O. A second Tris buffer (25 mM, pH 7.4) was made by diluting 
the 50 mM Tris buffer 1:1. A 1.5% stock solution of TWEEN 20 was made by bringing 
15 µl of TWEEN 20 to a volume of 850 µl of 25 mM Tris buffer and storing at room 
temperature for 2 weeks. A 10% BSA stock solution consisting of 1g in 10 ml of 25 mM 
Tris buffer, was made and stored at 4°C for 2 weeks. A stock FAD (7.5 mM) solution 
was made up by bringing 0.0328 g of FAD to a final volume of 5 ml of 25 mM Tris 
buffer, and stored at –20C. A 50 mM oxidized nicotinamide adenine dinucleotide 
(NADP) solution was made fresh by bringing 0.004 g of NADP to a volume of 100 µl of 
25 mM Tris buffer. Glucose–6-phosphate (150 mM in 25 mM Tris buffer) was made up 
fresh by adding 0.0123 g in 300 µL of 25 mM Tris buffer. Glucose–6-phosphate 
dehydrogenase (372 U/mg of protein) was made fresh by adding 17.34 µl in 10 ml of 
working solution. Menadione sodium bisulfate was made fresh by adding 0.007 g in 1 ml 
of 25 mM Tris buffer. A 0.3 mM dicoumerol solution (Solution A) in 5 mM KPO4 with 
0.5 % DMSO was made up to a pH of 7.4 and stored at room temperature. A 1 M stock 
of KH2PO4 was made up by bringing 13.6 g to a final volume of 100ml of ddH2O, and a 
1M stock of K2PO4 was made up by bringing 17.2 g up to a volume of 100 ml of ddH2O. 
To make a 0.1 M stock of potassium phosphate buffer, 7.22 ml of KH2PO4 and 2.78 ml of 
K2PO4 were brought to a final volume of 100 ml with ddH2O. From the stock solution a 5 
mM phosphate buffer was made up by adding 25 ml of the 0.1 M buffer and bringing it to 
a volume of 500 ml. To 0.02 g of dicoumerol 1 ml of dimethyl sulfoxide was added and 
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gently heated. To this 199 ml of the 5 mM phosphate buffer was added. An identical 
solution (Solution B) was made up but no dicoumerol was added to it. To make up a 30 
ml working solution, 15 ml of 50 mM Tris buffer (25 mM final concentration), 1.5 ml of 
10% BSA in 25 mM Tris (pH 7.4) (final concentration 0.005 %), 199.5 µl of 1.5 % 
TWEEN 20 (final concentration of 0.0001 %), 12.98 ml of ddH2O, 20.01 ml of 7.5 mM 
FAD (final concentration of 5 µM), 199.5 µl of 150 mM glucose-6-phosphate (final 
concentration of 1 mM), 18 ml of 50 mM NADP (final concentration of 30 µM), 66.85 µl 
of glucose-6-phosphate dehydrogenase (final activity 2U/ml), 0.009 g of MTT (final 
concentration of 0.7 mM) and 230 ml of 5 mM menadione (final concentration of 50 µM) 
were added. 
3.6.1.3.3 Tissue preparation 
 
Frozen liver tissue was ground with a homogeniser (Mickro-Dismembrator, B, 
Braun Biotech International GmBH) for 4 x 1 min at a frequency of 3,000 oscillations per 
minute and stored at–80 C until assayed. Liver tissue was diluted (1:100 dilution) in 50 
mM Tris buffer (pH 7.4) containing 1 mM EDTA. Samples were sonicated once for 3 
seconds and centrifuged at 16250 x g for 3 minutes.   
3.6.1.3.4 Kinetic assay 
To each microtitre plate well 55 µl of sample was added two times in triplicate. 
To one set of each sample Solution A (contains dicoumerol) was added and to the other 
set 50 µl of Solution B (does not contain dicoumerol), was added. To all of the wells, 200 
µl of working solution was added. Readings were taken with the pathcheck option on for 
intervals of 1 minute for a total of 5 minutes at a wavelength of 610 nm. The same 
spectrophotometer and software as described above were used. 
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3.6.1.3.5 Protein concentration 
Protein concentration was determined as described in section 3.4.1.2.4 except 
standards and samples were made up in 25 mM Tris buffer. 
3.6.2 Statistics  
 
Within the respective male and female SHRsp rat sets, samples were analyzed 
using an unpaired two tailed t-test. As a consequence of small sample size a non-
parametric Mann-Whitney U test was run for the male SD rats.
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Chapter 4 Results 
 
4.1. Male SHRsp Body Weights 
 Body weight in the male SHRsp control group ranged from 243.6 ± 4.6 g at the 
start of the feeding trial to 359.6 ±4.6 g at the end of the feeding trial. Male SHRsp in the 
broccoli group ranged from 253.1 ± 3.1 g at the beginning of the feeding trial to 375.9 ± 
3.1 g at the end of the feeding trial. Significant differences were detected between the 
control and broccoli fed groups, with the broccoli group being heavier at weeks 2, 3, 6, 7, 
8, 9, 10 and 11 with respective p values of 0.032, 0.013, 0.021, 0.011, 0.011, 0.051, 
0.015, 0.006 (see Figure 4.1). Groups were not significantly different at weeks 1, 4, and 5 
with respective p values of 0.095, 0.217, 0.504 (see Figure 4.1). 
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Figure 4.1. The effect of feeding 200 mg of dried broccoli sprouts on body weight in 
male SHRsp. Results are expressed as mean weight ± standard error of the mean (SEM). 
Groups were not significantly different by unpaired two tailed t-tests at weeks 1, 4, and 5 
(respective p values are 0.095, 0.217, 0.504). Groups were significantly different by 
unpaired two tailed t-tests at weeks 2, 3, 6, 7, 8, 9, 10, and 11 (respective p values are 
0.032, 0.013, 0.021, 0.011, 0.011, 0.051, 0.015, 0.006). Spontaneously hypertensive 
stroke prone rats (SHRsp) were fed a modified AIN-93G diet (Control) or a modified 
AIN-93G diet supplemented with 200 mg of dried broccoli sprouts (Broccoli) for 3 
months. 
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4.2 Female SHRsp Body Weights 
 
 Body weight in the female SHRsp control group ranged from 182.1 ± 3.9 g at the 
start of the feeding trial to 245.6 ± 3.5 g at the end of the feeding trial. Male SHRsp in the 
broccoli group ranged from 177.4 ± 2.9 g at the beginning of the feeding trial to 239.7 ± 
3.1 g at the end of the feeding trial. Groups were not significantly different throughout 
weeks 1 to 11 with respective p values of 0.349, 0.385, 0.379, 0.221, 0.192, 0.371, 0.194, 
0.224, 0.818, 0.217 (see Figure 4.2). Data for body weights in week 5 were not collected. 
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Figure 4.2. The effect of feeding 200 mg of dried broccoli sprouts on body weight in 
female SHRsp. Results are expressed as mean weight ±. SEM. Groups were not 
significantly different by unpaired two tailed t-tests (respective p values are 0.349, 0.385, 
0.379, 0.221, 0.192, 0.371, 0.194, 0.224, 0.818, 0.217 for weeks 1 to11). Spontaneously 
hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G diet (Control) or a 
modified AIN-93G diet supplemented with 200 mg of dried broccoli sprouts (Broccoli) 
for 3 months. 
 
 62
  
4.3 Male SHRsp Food Intake 
 Food intake in the male SHRsp was not significantly different with values of 
1562.9 ± 13.1 g in the control group and 1586.9 ± 11.2 g in the broccoli group (p = 
0.174) (see Figure 4.3).  
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Figure 4.3. The effect of feeding 200 mg of dried broccoli sprouts on total food 
intake in male SHRsp. Results are expressed as mean total food intake ±. SEM. Groups 
were not significantly different by unpaired two tailed t-tests (p= 0.174). Spontaneously 
hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G diet (Control) or a 
modified AIN-93G diet supplemented with 200 mg of dried broccoli sprouts (Broccoli) 
for 3 months. 
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4.4 Female SHRsp Food Intake 
 There was a significant difference in food intake in the female SHRsp between the 
control and broccoli groups with respective values of 1206.6 ± 16.2 g and 1158.5 ± 14.0 
g (p= 0.036) (see Figure 4.3).  
*
0
200
400
600
800
1000
1200
1400
Fe
m
al
e 
SH
R
sp
 fo
od
 in
ta
ke
/ 1
2 
w
ee
ks
 (g
)
Control (n=10) Broccoli (n=11)
 
Figure 4.4. The effect of feeding 200 mg of dried broccoli sprouts on total food 
intake in female SHRsp. Results are expressed as mean total food intake ±. SEM. 
Groups were significantly different by unpaired two tailed t-tests (p= 0.036). 
Spontaneously hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G 
diet (Control) or a modified AIN-93G diet supplemented with 200 mg of dried broccoli 
sprouts (Broccoli) for 3 months. 
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4.5 Experiment 1 
 
4.5.1 Plasma Dithiocarbamates 
 
 ITCs from broccoli sprouts are converted into DTC that can be detected to 
determine if the ITCs from the diet are absorbed. Levels of plasma DTC were 0.072 ± 
0.015 µM in the control animals and 0.47 ± 0.1 µM in the broccoli fed animals. DTC 
levels were significantly higher in the broccoli fed group than in the control group, with a 
p-value of 0.007 (see Figure 4.3).  
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Figure 4.5. The effect of feeding 200 mg of dried broccoli sprouts on plasma 
dithiocarbamate concentrations in male SHRsp. Results are expressed as mean ± 
SEM. Groups were significantly different by an unpaired two tailed t-test (p = 0.007). 
Spontaneously hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G 
diet (Control) or a modified AIN-93G diet supplemented with 200 mg of dried broccoli 
sprouts (Broccoli) for 3 months. 
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4.6. Experiment 2  
 
4.6.1 Blood GSH concentrations  
An increase in blood GSH concentrations is indicative of a decrease in oxidative 
stress. Mean (± SEM) blood GSH concentrations in male SHRsp were 6.8 ± 0.6 µM for 
the control group and 8.6 ± 0.5 µM for the broccoli group (see Table 4.1). Blood GSH 
concentrations were statistically different with a p-value of 0.03 (see Table 4.1). In the 
female SHRsp, blood GSH concentrations were 9.0 ± 0.8 µM for the control group and 
8.5 ± 0.9 µM for the broccoli group (see Table 4.1). No statistical difference was detected 
between the female broccoli and control groups (p-value = 0.669) (see Table 4.1).   
4.6.2 Plasma protein thiol concentrations 
An increase in plasma protein thiol concentrations can be used as a marker of 
reduced oxidative stress. In male SHRsp, mean (± SEM) plasma protein thiol 
concentrations were 163.9 ± 4.95 nmol/mg for the control group and 161.8 ± 5.4 
nmol/mg for the broccoli group (see Table 4.1). Broccoli sprout feeding had no 
statistically significant effect on plasma protein thiol concentrations in male SHRsp (p-
value = 0.771) (see Table 4.1). In the female SHRsp, plasma protein thiol concentrations 
were 188.4 ± 4.8 nmol/mg in the control group and 203.3 ± 4.4 nmol/mg in the broccoli 
group (see Table 4.1). Concentrations of plasma protein thiols were significantly affected 
by broccoli feeding in female SHRsp with a p-value of 0.033 (see Table 4.1).  
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Table 4.1. The effect of feeding 200 mg of dried broccoli sprouts on blood GSH and 
plasma protein thiol concentrations in male and female SHRsp.  
Animal 
Gender 
Groups Blood GSH 
 (µM) 
Plasma Protein 
Thiols 
(nmol/mg protein) 
Control (n=13) 6.8 ± 0.6   163.9 ± 4.5  
Broccoli (n=14) 8.6 ± 0.5   161.8 ± 5.4 
Male 
p-value  0.030*  0.771 
Control (n=10) 9.0 ± 0.8 188.4 ± 4.8 
Broccoli  
(n=11) 
8.5 ± 0.9 203.3  ± 4.4 
 
Female 
p-value 0.669  0.033* 
Results are expressed as mean ± SEM. Male blood GSH and female plasma protein thiol 
concentrations were significantly different by unpaired two tailed t-tests (with respective 
values of p = 0.030 and 0.033) Spontaneously hypertensive stroke prone rats (SHRsp) 
were fed a modified AIN-93G diet (Control) or a modified AIN-93G diet supplemented 
with 200 mg of dried broccoli sprouts (Broccoli) for 3 months.   
  
4.7 Experiment 3 
 
 4.7.1 Plasma albumin concentrations 
 
During the APR albumin concentrations decrease, therefore a decreased APR would 
result in increased albumin concentration. Mean (± SEM) concentrations of plasma 
albumin in male SHRsp in the control group were 29.2 ± 2.2 mg/ml and 31.0 ± 2.0 mg/ml 
in broccoli fed animals, with no statistically significant difference found between the two 
groups (p-value = 0.561). In the female SHRsp, concentrations of plasma albumin were 
28.3 ± 1.0 mg/ml in the control group and 27.6 ± 1.5 mg/ml in the broccoli group. No 
significant difference was detected between the control and broccoli group in the female 
SHRsp (p-value = 0.716).  
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 Table 4.2. The effect of feeding 200 mg of dried broccoli sprouts on plasma albumin 
concentrations in male and female SHRsp.  
 Groups Plasma 
Albumin  
(mg/ml) 
Control (n=13) 29.2 ± 2.2  
Broccoli (n=14) 31.0 ± 2.0   
Male  
p-value 0.561 
Control (n=10) 28.3 ± 1.0 
Broccoli  (n=11) 27.6 ± 1.5 
Female 
p-value 0.716 
Results are expressed as mean ± SEM and analyzed by unpaired two tailed t-tests. 
Spontaneously hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G 
diet (Control) or a modified AIN-93G diet supplemented with 200 mg of dried broccoli 
sprouts (Broccoli) for 3 months.  
 
4.7.2 Plasma ceruloplasmin levels  
 
Ceruloplasmin is a positive acute phase protein that increases during the APR. 
Decreased levels of ceruloplasmin would be indicative of a dampened APR. In male 
SHRsp plasma CP concentrations as shown by blot densitometry were 100 % in the 
control group and 95% in the broccoli group, with no significant difference between the 
two groups. In the female SHRsp, plasma CP blot densitometry were 100% in the control 
group and 94.7 % in the broccoli group. Levels of plasma CP were not statistically 
affected by broccoli feeding in male or female SHRsp, with respective p-values of 0.442 
and 0.571 (see Figures 4.7 and 4.9 with the respective blots in Figures 4.6 and 4.8).  
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 Figure 4.6. The effect of feeding 200 mg of dried broccoli sprouts on plasma 
ceruloplasmin levels in male SHRsp as shown by a western blot. Spontaneously 
hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G diet (C) or a 
modified AIN-93G supplemented with 200 mg of dried broccoli sprouts (B) for 3 
months. 
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Figure 4.7. The effect of feeding 200 mg of dried broccoli sprouts on plasma 
ceruloplasmin levels in male SHRsp. Results are expressed as mean percentage ± SEM. 
Groups were not significantly different by an unpaired t-test with a p-value of 0.442. 
Spontaneously hypertensive stroke prone rats (SHRsp) were fed a modified AIN-93G 
diet (Control) or a modified AIN-93G supplemented with 200 mg of dried broccoli 
sprouts (Broccoli) for 3 months. 
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4.8 Experiment 4 
 
4.8.1 Liver glutathione reductase activity 
 
Increased GR activity is a marker of phase 2 enzyme induction. In male SHRsp, 
mean (± SEM) GR activity was 10.2 ± 0.6 nmol/min/mg in the control group and 11.2 ± 
0.8 nmol/min/mg in the broccoli group (see Table 4.3). No statistically significant effect 
of broccoli feeding was detected in the male SHRsp (p-value = 0.268). In the female 
SHRsp, GR activity was 11.2 ± 0.6 nmols/min/mg in the control group and 10.4 ± 0.3 
nmols/min/ng in the broccoli group with no significant difference detected between the 
control and broccoli fed group (p-value = 0.243). In the male SD rats, GR activity was 
9.4 ± 1.2 nmols/min/mg in the control group and 9.9 ± 0.6 nmols/min/mg in the broccoli 
group. There was no significant effect of broccoli feeding in the male SD rats (p-value = 
0.827).  
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Table 4.3 The effect of feeding 200 mg of dried broccoli sprouts in SHRsp and SD rats on liver phase 2 enzyme activity.  
 
Results are expressed as mean ± SEM and analyzed by unpaired two tailed t-tests for the SHRsp and by a Mann-Whitney U test for 
the SD rats. P-values are for the effect of diet within rat category. Spontaneously hypertensive stroke prone rats (SHRsp) and Sprague 
Dawley (SD) were fed a modified AIN-93G diet (Control) or a modified AIN-93G and 200 mg of dried broccoli sprouts (Broccoli) for 
3 months.  
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Animal gender and 
strain 
Groups Glutathione
Reductase 
Activity 
(nmol/min/mg)
Glutathione –S-
Transferase 
(nmol/min/mg) 
Quinone 
Reductase 
(nmol/min/mg) 
Control   10.2 ± 0.6  216.5 ± 17.5  10.2 ± 1.0 
N 13 13 13 
Broccoli   11.2 ± 0.8  213.5  ± 12.2  11.0 ± 0.8 
N 12 13 13 
Male SHRsp 
p-value    0.268  0.887 0.539
Control   11.2 ± 0.6   283.6 ± 10.8  52.7 ± 2.4 
N 10 8 10 
Broccoli    10.4 ± 0.3  264.5 ± 6.4  64.6 ± 2.4 
N 11 11 11 
Female SHRsp 
p-value    0.243 0.001* 0.002*
Control   9.4  ± 1.2 363.9 ± 23.2  60.8 ± 14.0 
N 3 3 3 
Broccoli    9.9  ± 0.6 322.6 ± 7.9  96.6 ± 9.2 
N 3 3 3 
Male SD 
p-value    0.827  0.050* 0.127
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4.8.2 Liver glutathione-S-transferase activity 
 
During phase 2 enzyme induction the activity of GST is increased. Mean (± SEM) 
GST activity in the male SHRsp was 216.5 ± 17.5 nmols/min/mg in the control group and 
213.5 ± 12.2 nmols/min/mg in the broccoli group (see Table 4.3). No significant effect of 
broccoli feeding was detected in the male SHRsp (p-value= 0.887). In the female SHRsp, 
GST activity was 283.6 ± 10.8 nmols/min/mg in the control group and 264.5 ± 6.4 
nmols/min/mg in the broccoli group. For the female SHRsp, a boxplot was used to 
determine if there were any outliers. The values 232.81 and 212.75 nmols/min/mg were 
determined to be outliers. In the presence of the outliers, a p-value of 0.136 was obtained 
and removal of the outliers gave rise to a p-value of 0.001. In the male SD rats, GST 
activity was 363.9 ± 23.2 nmols/min/mg for the control group and 322.6 ± 7.9 
nmol/min/mg for the broccoli group. A significance value of 0.050 was determined for 
the effects of broccoli feeding in male SD rats. Levels of GST activity were the highest in 
the SD rats followed by the female SHRsp and then the male SHRsp. 
 
4.8.3 Liver quinone reductase activity 
 
Increased quinone reductase activity is a marker of phase 2 enzyme induction. 
Mean (± SEM) liver QR activity in male SHRsp was 10.2 ± 1.0 nmol/min/mg for the 
control group and 11.0 ± 0.8 for the broccoli group. There was no significant effect of 
broccoli feeding in the male SHRsp (p-value = 0.539). In the female SHRsp, QR activity 
was 52.7 ± 2.4 nmol/min/mg for the control group and 64.6 ± 2.4 nmol/min/mg for the 
broccoli group. A significant effect of broccoli feeding was detected in the female SHRsp 
 73
  
with a p-value of 0.002. In the male SD, QR activity was 60.8 ± 14.0 nmol/min/mg in the 
control group and 96.6 ± 9.2 nmol/min/mg in the broccoli group. A significance value of 
0.127 was detected for the effects of broccoli feeding on male SD rats. Levels of QR 
activity are the highest in the SD and female SHRsp category followed by the male 
SHRsp.  
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Chapter 5 Discussion   
Does the daily feeding of dried broccoli sprouts affect animal weight? 
Results from the body weight data show that there was a significant difference in 
male SHRsp body weights between the control and broccoli fed groups with the broccoli 
group being heavier for most of the time points during the feeding trial. The data on 
modified AIN-93G food intake shows that there was no significant difference between 
the control and the broccoli fed group, although the mean for the broccoli fed group is 
slightly higher than that of the control group. The increased body weight of the broccoli 
fed animals cannot be attributed to the broccoli fed group consuming more modified 
AIN-93G food than the control group.  
There is no available expected energy intake for SHRsp. Male SHRsp were fed 
approximately 20 g of AIN-93G diet per day, and it was assumed that this was providing 
ad libitum energy intake based on the food consumption of adult male Fisher rats of 12-
15 g per day. Therefore, a limitation of this study is that the male SHRsp were not strictly 
fed ad libitum. 
A greater weight gain in the broccoli group may be due to extra kilocalories taken 
in from the broccoli sprouts. The number of kilocalories provided by the consumed dried 
broccoli sprouts is estimated to be in the range of 1 kilocalorie per day in addition to their 
energy intake of approximately 80 kilocalories per day from the modified AIN-93G diet. 
This value is taken from the United States Department of Agriculture nutritional database 
and is based on the kilocalories present in dried brussel sprouts as there were no reliable 
data for the energy content present in dried broccoli sprouts. Over 12 weeks the broccoli 
group would have consumed an extra 84 kilocalories compared to the control group. This 
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amount translates into an estimate of 10.9 g of body weight using the crude estimate that 
0.454 kg of body weight equates to 3500 kilocalories. The difference in body weight 
between the control and the broccoli fed group is approximately 16 g. Therefore a portion 
of the 16 g of increased weight in the broccoli group may be attributed to the kilocalories 
present in the broccoli sprouts.  
An alternate explanation to the increased weight gain in the broccoli fed SHRsp 
may be increased feed efficiency. This would be the case if the feeding of broccoli 
sprouts altered gastrointestinal function and increased nutrient absortion. 
In other studies from our lab where male SHRsp were fed approximately 17 g of 
modified AIN-93G daily, the feeding of dried broccoli sprouts decreased inflammation in 
the cardiovascular system (Wu et al., 2004) and central nervous system (Ashraf et al., 
2004 submitted). Therefore even if these animals are experiencing a mild caloric 
restriction, some of the results observed may be due to the actions of the dried broccoli 
sprouts. In addition, when the data are expressed as a total change of body weight from 
the start of the feeding trial until their time of perfusion, then there is no significant 
difference in weight gain between the control and broccoli fed groups. This suggests that 
even if the animals were fed slightly below their dietary requirement, both groups were 
restricted to roughly the same extent.   
In the female SHRsp, there was no significant difference in body weight between 
the control and the broccoli fed animals, although the broccoli-fed animals significantly 
reduced their intake of AIN-93G diet. The female SHRsp consumed approximately 17 g 
out of the 20 g of modified AIN-93G that they were fed daily. There was usually food left 
over for all of the animals. Therefore it is safe to assume that the female SHRsp were fed 
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ad libitum and the results that are obtained are due to the effects of the dried broccoli 
sprouts. It is possible that the broccoli fed animals were compensating for the kilocalories 
obtained in their diet from the dried broccoli sprouts and therefore consumed less of the 
AIN-93G diet. 
Can the ITCs in the dried broccoli sprouts be detected in the plasma of SHRsp? 
 
The procedure used for examining ITC concentration in my study has been used to 
study the effects of glucosinolate consumption in humans (Liebes et al., 2001; Shapiro et 
al., 2001; Ye et al., 2002). When a dose of 200 µM of isothiocyanates was administered 
to humans, peak concentrations of ITCs were reached at 1 hour, and by 8 hours 58.3 ± 
2.8% of the dose was detected (Ye et al., 2002). No pharmacokinetic studies examining 
the long-term administration of dried broccoli sprouts have been performed in rats. 
Therefore it is not possible to say what theoretical concentration of ITC concentration in 
the plasma of SHRsp should be present after 3 months of broccoli sprout administration. 
Results from Experiment 1 demonstrate that concentrations of DTC, which are 
reflective of ITC concentration in the plasma of the broccoli fed animals, were 
significantly higher than those in the control group. Since glucosinolates which are 
converted into ITC and then into DTC are primarily found in the Cruciferae family of 
vegetables (as reviewed in Fahey, 2001), there should not have been glucosinolates in the 
diet of the control group. In the control group, the detection of low levels of DTC 
occurred due to incorrect sample preparation. Either rubber from the vacutainer lids or 
the latex gloves used is believed to have contaminated the samples. Within the broccoli 
group the variability in the DTC concentration was higher than expected. This variability 
can be accounted for by the time duration over which the samples were collected. In my 
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study, SHRsp were fed dried broccoli sprouts 24-31 hours before they were perfused. 
Ideally all of the animals would have had their blood collected at the same time from 
their last feeding. 
Despite the issues raised concerning the way in which blood was collected, the 
difference observed in ITC concentration between the control and the broccoli group is 
thought to be reliable and indicative of the absorption of ITCs from the broccoli sprouts 
in the diets of the broccoli fed animals. 
 
Does the daily feeding of dried broccoli sprouts decrease oxidative stress in blood? 
 
The feeding of broccoli sprouts increased blood GSH concentration in male but 
not female SHRsp, whereas protein thiol levels were increased in female but not male 
animals. Overall, levels of protein thiols are higher in female SHRsp than in male SHRsp.  
Blood GSH and protein thiols were used as markers of oxidative stress (Asensi et 
al., 1999; Hu, 1994), with an increase of either of these markers thought to be indicative 
of less oxidative stress. Respective concentrations of blood GSH and plasma protein 
thiols in rats is 20 µM and 300-500 µM (Hu, 1994). The amounts obtained in my study 
fall below this range. This may be due to the rat strain used in this study. This increase of 
blood GSH in males suggests that they were experiencing less oxidative stress and the 
increase in protein thiols in the females with broccoli sprout feeding suggests that they 
were experiencing less oxidative stress. However if both the male and female animals 
were experiencing less oxidative stress, then one would expect that both markers of 
oxidative stress would reflect this. A battery of tests is needed to reliably detect oxidative 
stress. Therefore, a limitation of this study is that only two markers of oxidative stress 
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were examined. Regardless of this limitation, the results that are observed in my study 
may be indicative of a gender effect in the SHRsp.   
A number of studies provide evidence for a gender effect between male and 
female SHRsp. Female SHRsp experience lower blood pressure (Kato et al., 2003; Kerr 
et al., 1999), less kidney damage (Gigante et al., 2003), lower superoxide generation 
(Kerr et al., 1999) and smaller infarct size following stroke (Carswell et al., 1999) than 
male SHRsp. This gender effect appears to be dependent on diet and age. Blood pressure 
is higher in male SHRsp than in female SHRsp on a stroke permissive diet (5% fat; 0.4% 
sodium, and 0.75% potassium). However, if the same male and female SHRsp at the age 
of 20 weeks are then salt loaded for 1 month, then their blood pressure does not differ 
(Kato et al., 2003). Further evidence supporting an interplay between gender, age and diet 
is shown in a study by Kato et al., (2003). Screening of SHRsp male and female rats for 
quantitative blood pressure loci in the genome revealed the importance of sex, age and 
diet on blood pressure (Kato et al., 2003). Some blood pressure quantitative trait loci 
were present only in females, some were expressed only at certain ages, and some were 
more prominent on a salt loaded diet. Results from my study that support a gender effect 
are for blood GSH concentration, plasma protein thiols concentration, and activities of 
GST and QR. Results from this study that do not show a gender effect are those for 
albumin concentration, CP concentration and GR activity. It is possible that since there is 
an interplay between age and gender, a lack of gender effect in some of the parameters 
that I observed may be a consequence of animal age, even though the animals were age-
matched.  
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A limitation of the experimental design in this project is that the estrous cycle of 
the female animals was not followed. It is possible that in the female SHRsp an increase 
in blood GSH concentrations induced by broccoli may occur at other times in the estrous 
cycle. Another possibility is that protein thiols concentration may decrease at different 
times of the estrous cycle. More studies are required whereby the effects of estrous 
cycling on parameters of oxidative stress are examined. During ischemia female SHRsp 
in metaestrus had larger brain infarcts than both females chosen at random and male 
SHRsp (Carswell et al., 1999). Carswell et al., (1999), therefore emphasizing the 
importance of gender and the stage of the estrous cycle on outcome in ischemia. It is 
possible that parameters other than infarct size may be influenced by estrous cycling.  
What is evident from the examination of blood GSH and protein thiol 
concentrations is that there is an interaction between the effects of dried broccoli sprouts 
and animal gender. There are few studies that use both male and female SHRsp as a 
model. This study highlights the findings of a gender effect in SHRsp. 
Does the daily feeding of dried broccoli sprouts decrease the APP? 
 
 The daily feeding of dried broccoli sprouts to SHRsp does not appear to have any 
effect on APPs as evidenced by no significant difference in albumin and ceruloplasmin 
levels between the controls and broccoli fed animals for both the male and female 
SHRsp. It is possible that the SHRsp are experiencing changes in APP that are not being 
detected due to the experimental design used in this study. Albumin and CP may not be 
sensitive enough markers for detecting a change in APP and other markers may be more 
sensitive. A proteomics approach such as that used by Sironi et al., (2001), which showed 
that SHRsp experience an APR, may be more suitable. The technique used to detect APP 
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in my study is western blotting. Western blotting is a semi-quantitative technique, which 
is more suitable for detecting large differences between groups. Western blotting may 
therefore have lacked the sensitivity to detect changes in APP in my study. Also, the 
SHRsp may experience changes in APP that are dependant on their age. Sironi et al used 
male SHRsp that were approximately 13 weeks old, whereas, the animals used in this 
study were perfused at 35 weeks of age. The animals in Sironi’s study (2001), lost 10% 
of their body mass over time, whereas the animals in my study did not suffer from any 
weight loss. Therefore the experimental conditions namely, diet and age in Sironi’s study 
may account for the increased presence of certain proteins in the serum and urine of 
SHRsp compared to SHR and WKY animals. 
 The other alternative is that in Sironi’s study the SHRsp are not experiencing an 
APR. In the study by Sironi, the SHRsp are on a diet that is supplemented with 1 % 
NaCl. Given that SHRsp are salt sensitive and that this sensitivity is associated with renal 
damage as shown by proteinuria (Griffin et al., 2001), the SHRsp may be experiencing 
kidney damage whereby larger proteins pass through the kidneys and are released into the 
urine. Sironi detected more profound changes in urine proteins than in serum proteins and 
perhaps this is more indicative of kidney damage. 
 Drawbacks in experimental design of my study include the lack of a control strain 
of rat, no time and dose response curve for the dried broccoli sprouts, and the type of diet. 
In the absence of a control strain of rat, it is not possible to determine if both the broccoli 
and control groups were or were not experiencing an APR.  
 Another issue is the dose of broccoli sprouts that was used in my study. It is 
possible that a 200 mg dose of dried broccoli sprouts is not enough to dampen the APR. 
 81
  
A dose response curve would be useful in determining the effects of dose on APP. Also, 
the time at which the broccoli sprouts were administered may have been too late. At 2 
months of age the SHRsp are already developing high blood pressure. Perhaps if the 
broccoli sprouts were administered earlier then an effect would be observed. Also at the 
time when the SHRsp were perfused they may have been too old for the broccoli to be 
effective. A time response curve for the broccoli sprouts would reveal if broccoli sprouts 
influence the APP in an age dependant manner. Lastly, the nature of the diet that the 
SHRsp were on may affect the APR. The SHRsp in my study were on a diet that is not 
supplemented with NaCl unlike that of Sironi et al. (2001), in which the animals received 
a diet that was NaCl supplemented. In the presence of a NaCl supplemented diet broccoli 
may have been effective at lowering an APR. 
Does the daily feeding of dried broccoli sprouts induce phase 2 enzymes? 
 
The activity of GR was not significantly different for either the male or female 
SHRsp nor for the SD rats. A gender effect was seen for GST and QR whereby the 
feeding of dried broccoli sprouts influenced values in the female SHRsp and not those of 
the male SHRsp. Overall activity levels were higher for the female SHRsp compared to 
the male SHRsp for GST and QR. The activity for QR was the highest in the SD rats 
compared to the female and male SHRsp. 
Possible explanations for the results are that the regulation of phase 2 enzymes 
may be gender dependent, differentially controlled, and rat strain dependent. The gender 
differences seen in SHRsp are discussed above. The results obtained from GST and QR 
provide further examples of a gender difference between male and female SHRsp. 
Estrogen may play a role in the regulation of phase 2 enzymes. Other than via 
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electrophilic inducers, it is thought that phase 2 enzyme induction occurs when 
antiestrogens bind estrogen receptors that then bind to the electrophilic response element 
(Montano and Katzenellenbogen, 1997). Montano et al. have demonstrated that QR, 
GST-Pi and GCL are upregulated by an estrogen receptor mediated mechanism (Montano 
et al., 2004). Antiestrogens are compounds that compete with estrogen for the estrogen 
receptor and can act as either antagonists or agonists. There is some evidence that 
suggests that estrogen decreases the activity of phase 2 enzymes (Ansell et al., 2004). 
However compounds such as resveratrol that are phytoestrogens have been shown to 
induce phase 2 enzyme activity (Mizutani et al., 2000). This discrepancy between the 
roles played by agonistic versus antagonistic estrogenic effects may be accounted for by a 
study performed by Ansell et al., (2004). The administration of phytoestrogens and 
estrogenic and antiestrogenic compounds shows that estrogen receptor signalling to the 
ARE is dependent on cell type, ligand, and receptor (Ansell et al., 2004). From the results 
of my study, estrogen in the presence of broccoli sprouts may be increasing QR activity 
and downregulating GST activity. This suggests that the effect of estrogen in the presence 
of broccoli on phase 2 enzymes is differential in that it can vary from enzyme to enzyme. 
Alternatively, different elements may be present in the promoter region of the 
respective phase 2 enzymes, explaining the differential effects of broccoli on GST and 
QR in the female SHRsp. For example, the phase 2 enzymes GCL and GST have a κB 
element in their promoter region and can therefore be activated by oxidative stress (as 
reviewed in Hayes and Pulford, 1995). It is possible that oxidative stress in the SHRsp 
control group upregulates GST activity.  
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 Another explanation for the results obtained for GST is that broccoli is down 
regulating GST activity via either the ARE or other products that are in broccoli. This is 
plausible given that GST plays a role in Sul metabolism. Sul enters cells and forms DTC 
which are the products of ITCs reacting with thiols such as GSH (Zhang, 2000; Zhang, 
2001; Zhang and Talalay, 1998). The accumulation of these DTC can result in phase 2 
enzyme induction (Ye and Zhang, 2001). Given that GST catalyzes the formation of 
glutathiol adducts, the upregulation of phase 2 enzymes may be a consequence of 
requiring GST for Sul metabolism. Most studies that examine the effects of Sul on phase 
2 enzyme induction are short term studies. It is possible that long term administration of 
Sul results in a negative feedback loop thereby decreasing GST activity. 
Lastly, a limitation of the assay used to detect GST is that it is biased towards 
certain GST isoforms. The GST family of enzymes is comprised of about 5 related 
families namely, alpha, mu, pi, sigma and theta (as reviewed in Hayes and Pulford, 
1995). CDNB has a high affinity for the Mu subfamilies M1 and M2), a moderate affinity 
for alpha and Pi subfamilies A1, A2 and P1, a low affinity for the Mu subfamily M3, and 
no affinity for the theta sub families (as reviewed in Eaton and Bammler, 1999). This 
suggests that there may be an upregulation of a specific GST subfamily in the broccoli 
fed group but this assay is not sensitive enough to all of the GST isoforms to detect it. 
The lack of sensitivity of the assay may also account for the lack of a significant 
difference in the male SHRsp. Males have higher levels of the M3 and M4 subfamilies of 
the GST Mu family than females (as reviewed in Tsuchida and Sato, 1992). Therefore, if 
in males the M3 subunit is upregulated, CDNB has a low affinity for M3 and will not 
maximally detect it.  
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The induction of GR and GST in SHRsp demonstrates tissue specificity. Work in our 
laboratory has shown that the administration of dried broccoli sprouts increases the 
activity of GR but not GST in the aorta of male SHRsp (Wu et al., 2004 and unpublished 
work). I have demonstrated that in the liver the activity of GR does not change where as 
that of GST decreases with administration of dried broccoli sprouts. Phase 2 enzymes 
have been shown to exhibit tissue specificity (as reviewed in Pickett and Lu, 1989). 
Preliminary data from the male SD rats suggest that in the liver, the activity of GST is 
a little higher and QR is about six times higher than in male SHRsp. Activities of GST 
and QR in the female SHRsp are closer to those of the male SD rats than are the activities 
of GST and QR in the male SHRsp compared to the male SD rats. It is possible that the 
activities of GST and QR reflect better overall health in female SHRsp than male SHRsp 
since female SHRsp experience lower blood pressure (Kato et al., 2003; Kerr et al., 
1999), less kidney damage (Gigante et al., 2003), lower superoxide generation (Kerr et 
al., 1999) and smaller infarct size (Carswell et al., 1999). Male SHRsp have been 
described to undergo premature central nervous system ageing (Ashraf et al., 2004 
submitted) Given that the severity of the pathologies is worse in male SHRsp compared 
to female SHRsp, perhaps overall male SHRsp experience accelerated ageing. If GST is 
required for Sul metabolism, and the activity of GST is mirrored in female SHRsp by the 
control SD rat, then perhaps Sul metabolism is altered in the male SHRsp. 
Pharmacokinetic studies on the long term administration of broccoli sprouts would be 
required to test this hypothesis. 
Concluding remarks 
 85
  
The findings for oxidative stress, APPs and phase 2 enzyme induction do not 
present a clear pattern to support the hypothesis that, the dietary intake of broccoli 
sprouts by inducing phase 2 enzymes in the liver will decrease oxidative stress and the 
acute phase response in the blood of SHRsp. In male SHRsp, broccoli feeding resulted in 
significantly higher levels of blood GSH relative to control diet but no differences were 
detected in protein thiol concentration, CP levels, albumin concentration, GR activity, 
GST activity or QR activity. In female SHRsp, broccoli feeding resulted in significantly 
higher levels of protein thiol concentration and QR activity, and lower levels of GST 
activity, whilst no difference was detected in blood GSH concentration, CP levels, 
albumin concentration or GR activity. For liver enzyme activity, broccoli feeding in male 
SD rats resulted in a significant difference in GST activity, but not in GR activity. A 
larger sample size may have rendered QR activity significant. There were some 
similarities between the male and female SHRsp with respect to albumin concentration, 
CP concentration and GR activity, which did not change significantly as result of diet.  
The mechanism by which dietary intake of broccoli sprouts affect parameters of 
oxidative stress and phase 2 enzymes is unclear and appears to be further complicated by 
animal gender. An extension of this work would be to incorporate the ITC into the 
modified AIN93-G diet and then: 1) further examine the role of estrogen and Sul on 
phase 2 enzyme induction in various tissues of female SHRsp 2) perform a time response 
curve for the administration of ITC to examine if the protective effects exerted by Sul 
exhibit a temporal pattern 3) examine phase 2 enzyme protein levels of GR, GST and QR 
in both male and female SHRsp and SD rats 4) utilise 2-D protein gels to look at an 
increased number of APP such as transferrin, haemopexin, haptoglobin and 5) examine 
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other parameters of oxidative stress such as 4-hydroxynonenal, protein carbonyls, and 8-
hydroxyguanosine (these are respective markers of lipid, protein, and DNA modification 
due to increased levels of oxidative stress).   
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